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Chapter I 
GENERAL INTRODUCTION 

The urinary hladder 
The urinmy bladder is a patt of the urinmy system. Together with the pyc1l1Il1, ureters 
and urethra, the urinary bladder is responsible for the excretion of urine. The urinalY bladder 
Ilmctions herein ns a temporary reservoir for the urine. Whenever it is necessmy the urine in 
the uril1U1Y bladder can be voided. The urinalY bladder is characterized by its distensibility. 
The special anatomicnl stl1lctllre of the urinary bladder \vall is adapted to fulfill this. The 
urinary bladder wall consists of three main layers: a smooth muscle layer, a stromal 
compartment, and a mucosal layer. The smooth muscle layer consists of an extcrnal and 
internal layer of longitudinal libers, and a middle layer of circular muscle libel's. These 
sl1100th muscle layers arc neccssmy for emptying of the bladder. The stromal compat1ment of 
the lIrinalY bladder wnll consists of loosely packed connective tissue, including bloodvessels 
nnd nerve tlbers. The mucosallaycr (i.e. urothclium or transitional epithelium) is the internal 
lining of the bladder. In humans, the urothelium consists of live to seven polarized cell layers. 
In the mouse, it consists of three layers. At the basement membrane side of the urotheliulll the 
undifferentiated basal cells are located. These basal cells contain the stem cells of the 
lIrothelilllll. Under normal conditions the cell turnover of the urothelium is very low, but after 
injury to the bladder wall basal cells start to divide rapidly. At the luminal side of the 
urothclillm, large superficial cells (umbrella cells) cover the urothelial cell layers. These 
umbrella cells form a barrier between the urine and the body tluids and they are important for 
the plasticity of the bladder. Betwecn the superficial cell layer and the bnsal cell layer, the 
intermediate cell layers nre located. 
Bladder Cancer 
Etiology & Epidemiology 
Bladder cancer is the fifth most common malignancy in males in the western society 
[Parkin ef al .• 1999]. In 1990, an incidencc of 24.2 (male) and 6.6 (female) pcr 100,000 
people was repOlied in Western Europe [Parkin et al., 1999]. In the Netherlands, an incidence 
of 23.4 (male) and 4.3 (female) per 100,000 people was reported for 1995 
(http://www.ike.nLlvvikl). The risk for the development of bladder cancer increases with age, 
with a peak incidence around the seventh decade of life. Epidemiological studies have 
revealed some impol1ant risk factors, like the use of tobacco, exposure to aromatic amines, 
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chronic urinary tract infection, and infection with Schistosoma hematobium [Johansson & 
Cohen, 1997]. It is estimated that cigarette smoking accounts for 25-60% of bladder cancer 
cases in industrialized developed countries, and is therefore the most important known risk 
factor for bladder cancer. [Johansson & Cohen, 1997]. In developing countries, infection ,vith 
Schistosoma hematobiulII is responsible for ± 75% of the detected cases of squamous cell 
carcinoma in the bladder. 
Pathology 
In the \vestem society, more than 95% of the bladder tumors are transitional cell 
carcinomas (TeC). Other urinmy bladder hUllors are squamous cell carcinoma, mixed 
carcinoma, adenocarcinoma, and nonepithelial bladder hllnors. TCC (the topic of this thesis) 
can be further categorized into flat lesions (e.g. carcinoma ;'1 s;tu), papillary neoplasms, and 
invasive neoplasms [Epstein e{ al., 1998] Histologically, papillmy TCC are graded according 
to the WHO grading system: Grade 1 are papillary structures lined by neoplastic transitional 
epithelial cells that show minimal nuclear abnormalities and mitoses; in Grade 2 the 
histological and cytonuclear features are between those of grade 1 and 3; Grade 3 is 
characterized by signit1cant nuclear abnormalities and high number of mitoses. Non-papillary 
bladder carcinomas are invasive and usually grade 3. Currently, histological grade and 
clinico-pathological staging are the best predictors of clinical prognosis [Bane et al., 1996]. 
Nowadays, the TNlv:l-c1assit1cation (Fig. 1) is the best known and worldwide most frequently 
lIsed system for staging of bladder cancer. In the TNM cI<lssific<ltion the extent of the primary 
hllnor (T), the involvement of regional lymph nodes (N) and the presence or absence of 
distant metastases arc detcrmined. 
UmtheliuJ11 
Stroma 
l\'1usclc 
Normal Tis 'fa T1 1'2+ 
N+,IVl+ 
-----'-+ 
Figure 1: Schematic representation (?l the TNM '~J'Stem fhl' the clas·~·Uicatio}/ (?l bladder 
Cll1u:eJ'. 
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From a clinical point of view Tee can be separated into superficial tumors and muscle 
invasive hunors because the natural histOlY and treatment of these two Fon11s are markedly 
different [Lapham et al., 1997; Raghavan ef al., 1990]. More than 70% of patients with Tee 
are initially diagnosed with superficial tumors (Ta, Tt and Tis). Superficial Tee are treated 
by transl1l'ethral resection (TUR), followed by adjuvant ehemo~, or immunotherapy [Soloway, 
t 992]. Progression to invasive disease is uncommon for patients with superficial Tee, and 
long-term survival has been achieved in more than 80% of the cases [Raghavan, 1990; Bane, 
1996]. On the other hand, patients with muscle invasive Tee (T2+) have a vmy poor 
prognosis. The standard primary treatment for locally advanced Tee is radical cystectomy, 
sometimes in combination with adjuvant chemo-, or immunotherapy [Badalamcnt and 
Schervish, 1996; Lapham et al., 1997]. Despite these radical therapies, the reported five-year 
survival rate for invasive bladder carcinoma is less than 50%. 
Recurrence of superficial bladder cancer 
The major problem in thc management of supert1cial Tee is the high frequency of 
tumor recurrenecs. Over 70% of patients with superficial Tee will have one or more 
recurrences atter initial treatment, and one-third of those patients has progression to invasive 
disease and eventually succumbs to their disease [Heney et al., 1983; Kurth el al., 1989]. 
Several potential mechanisms may account for the high recurrence rate of hi adder cancer: 
I) Field cancerization. 
An important feature of Tee is its multifocal nature. Biopsies of nOllnal appearing areas in 
bladders harboring a tumor revealed a high incidence of hyperplasia, atypia, CIS, or cancer 
[Schade and Swinney, 1973; Heney et al., 1978; \Volf and Hojgaard, 1980]. Histological 
mapping of cystectomy specimens of patients with Tec dcmonstrated that abnormalities of 
the surrounding urotheliulll were common [Farrow, 1976; Koss, 1977a]. These abnormalities 
ranged fi'om hype'1)lasia and dysplasia to CIS and carcinoma. Furthermore, \Volf and 
Hojgaard [1983] reported that the presence of urothelial dysplasia concomittant with a bladder 
hUllor is an important determinant for future recurrences. These shldies suggested that some 
of the observed recurrences are achmlly new primalY bladder tumors, derived 11'0111 areas of 
atypia or els that had progressed. The occurrence of these nmltiple, abnormal areas in the 
bladder could be explained by the "Held cancerizationl ' hypothesis [Slaughter et al., 1953]. 
According to this theory, an entire field of tissue (bladder mucosa) is exposed for a long time 
to carcinogens. The carcinogenic exposure affects multiple cells in thc field, which leads to 
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the occurrence of many genetically unstable cells. Ultimately, prolifcration and fm1her 
progression of such unstable cells can result in aberrant growth and the formation of multiple 
independent tumors. On the basis of this "field cancerization" hypothesis, some authors 
suggested that each recurrent bladder tumor had arisen de 110VO fi'ol11 precancerous nat 
urothelium [Richie et al., 1989]. 
II) Regrowth of an incompletely resected primmy bladder tumor. 
Standard treatment of superf1cial Tee is a local resection of the hUllOr. If the resection is not 
complete, this could lend to the outgrowth of residual tumor cells ultimately resulting in a 
recurrent Tee. Although this seems a vmy obvious explanation for the appearance of 
recurrences, it is in contradiction \'lith the observation that 1110St new bladder tumors appear at 
a site different from the prinullY tumor [Boyd and Burnand, 1974]. In addition, careful 
microscopic examination of the scar area after resection of the primary tUl110r did not reveal 
residual cancer cells [Badalament, 1996]. 
III) Implantation of intraluminally dispersed cancer cells (Fig 2A). 
Several clinical and experimental studies indicate that recurrences could be thc consequence 
of shedding and subsequent reattachment of hlluor cells to intact or traumatized areas of the 
urotheliul11. 
• o· f • • • A • • • 
* 
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Figure 2: Mechanisms that could be im'o/\'cd ill the del'e/opmel/t (?f' bladder tumor 
rec/lrrences. A) Intralulllinal shedding and subsequent attachment oj'tumor cells Oil either 
;'ltact' OJ' fra/{lIIatized~ IfI'VtheUU111 B) Lateral illtraepUhelial spl'ead;;lg o.lsingle tumor cells 
oJ's/teels albladder tumor cells. U=lIl'Otlielilf/}/, P=pr;'lI01)' 11111101'. 
Hinnwll (1958) was one of the first to suggest that intrnluminally shedded bladder tumor cells 
could attach to areas in the bladder, remote from the location of the prinuuy huuor. In several 
ill I'ivo models it was shown that bladder hunor cells could attach to traumatized areas in the 
bladder [Soloway and Masters, 1980; See et al., 1989; See et al., 1990; Hyacinthe et al.~ 
1995]. Although less frequently, ill vivo attachment of bladder tumor cells to intact areas of 
the bladder was also reported [Soloway, 1980]. More recently, it was shown that bladder 
tumor cells are indeed able to attach to and colonize intact urothelium in vitro [Rebel et al., 
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1994a], The latter study showed that expression of the adhesion molecule E-cadherin by the 
bladder tumor cells was a requisite for the observed adherence to intact urathelium, 
IV) lntraepithelial expansion of cancer cells (Fig 28), 
An altelllative mechanism could be lateral expansion of bladder tumor cells into the 
sUlTounding normal urothelium [Harris and Neal, 1992; Garcia et al., 1999J. This could either 
be accomplished by single tumor cells or sheets of tumor cells migrating ;\\vay from the 
primary bladder tumor (Fig 28). 
Mechanisms III and IV Hre supported by recent molecular genetic studies of bladder 
tumors, These studies revealed that at least in some individuals tUlllor reCUlTences arc of the 
same clonal origin. Demonstration of monoelonality in multiple synchronous or 
metachronous bladder tumors was bascd on methods such as X-chromosome inactivation, 
mutation analysis of specific genes (e.g, P53, Rb), and microsatellite analysis [Sidransky el 
al., 1992; Habuchi el al., 1993; Miyao et al., 1993; Chern et al., 1996; Takahashi et aI., 1998]. 
i'V1olloclonality of thesc tumours suggested that recurrences could arise by reimplantatioll or 
intracpithelial expansion of (residual) tumor cells and subsequent proliferation of bladder 
tumor cells with selective growth advantages [Foresman and Messing, 1997], 
Cnrcinomn ill situ of the urinary blnddel' 
Carcinoma ill situ (CIS) of the bladder can be regarded as an intraepithclial neoplasia 
(lEN). CIS is a full-thickness malignant (high-grade) change that is confined to the flat 
(nonpapillmy) urothelillll1 (Fig. 3), i'V1OlVhologically, CIS is characterized by llrothelilll11 of 
variable thickness, which exhibits cellular atypia of the entire mucosa, from thc basal layer to 
the surface [:Nlurphy et al., 1994], By definition, there is no invasion of the underlying 
basement membrane. In approximately 10% of CIS a "pagetoid variant" is noted [Orozco el 
al., 1993]. In this variant individual or small groups of transtormed cells arc found in the 
sUlTounding, normalurothelium of the CIS. CIS is often multifocal, and is usually observed in 
association \vith either synchronous or metaehronous papillary or invasive TCe. Only in 10% 
of the patients CIS is diagnosen as the sole lesion in the bladder [Hudson and Herr, 1995], 
Although CIS has a cytological resemblance to high-grade carcinoma, expansion occurs only 
by undermining the adjacent normal urothelium. Even under HlVorable conditions (e.g. large 
mucosal defects due to diagnostic biopsies or therapeutic fulguration) the cells of CIS usually 
do not invade stromal tissue [rvlurphy, 1994; Orozco et al. 1994J, However, at longer time 
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intervals progression to invasive disease is also frequently repOlied [Lamm, 1992; Hudson 
and Herr, 1995; Cheng ef al., 1999]. 
Figure 3: Carcinoma ill situ (?Ohe urinal), bladder. 
The clinical course of patients with CIS is difficult to predict. Laml11 (1992) compiled 
the literature data on CIS of the urinmy bladder and reported an average incidence of 
progression to muscle invasive disease of 54%. Furthermore, the OCCUlTence of CIS in the nat 
urothelium adjacent to hUllors is correlated with a higher probability of tumor recurrences 
andlor invasion [Althausen et al., 1976; \Veinstein et al., 1985]. On the other hand, a 
signiticant minority of patients with isolated CIS will never have progression to invasive 
disease [Riddle ct a1., 1975; FmTow et al., 1976]. This strong variation in natural history has 
lead to the suggestion that CIS of the urinal}' bladder may, in fact, be a group of diseases with 
at least two distinct tonns, one being aggressive and the other being relatively indolent 
[Weinstein ef al., 1980; Droller and Walsh, 1985]. 
Although the clinical behavior of CIS is variable, CIS is in general regarded as a 
precursor lesion for invasive carcinoma. That CIS, nowadays, is regarded as the most likely 
precursor lesion tor invasive carcinoma is based on evidence gathered from mapping shldies, 
follow-up studies and genetic analyses. First evidence tor a preexisting CIS phase before the 
onset of invasive carcinoma came from mapping studies of cystectomy specimens [Riddle et 
al., 1975; Farrow ef al., 1976; Koss ef al., 1977b; Ulz and Farrow, 1984; Kakizoe ef al., 1984 J 
and il'Oll1 follow-up studies [Fan"ow et al., 1977]. These studies showed that CIS is related in 
space and in time to carcinoma. FlIlihennore, mutation and loss of heterozygosity (LOH) 
analyses have shown that CIS displays the same genetic alterations as invasive Tee; p53 
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gene mutations and LOH of chromosome 14q are frequent both in CIS and invasive TCC 
[Spmck el aI., 1994; Rosin el a1., 1995]. 
The reported histological and DNA abnormalities in cells of CIS documcnt the 
malignant potential of CIS, but additional changes/fllCtors are probably required before 
progression to invasive disease can occur. To date, high risk factors that are associated with 
the progression of CIS to invasive disease arc diffuse growth, prostatic involvement, 
ovcrexpression of p53 or prolifcration-, surface- or tumor-associated markers and loss of 
nonnal urothelial antigens [Hudson and Herr, 1995]. 
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:Models for thc study uf implantation and intntcpithelial expansion of bladder cancers 
III vitro alld in vivo lIIodels/or tlte stl{({l' q/bladder tumor cell implantation 
Implantation of shedded tumor eells is facilitated by the wounding of the urothelium 
[Soloway and Masters, 19XO]. Urothclial injury exposes the basement membrane and its 
underlying structures, which contain extracellular matrix proteins (ECM), like luminill, 
collagen type IV, fibronectin and fibrin [Davis and A vots-A vioOn, 1982; Pode et al., 1986]. 
Thcrefore, ill vitro tumor cell adherence assays study the attachment of bladder hll110r cells to 
ECM-precoated culture dishes. Several studies showed that especially t1bronectin promoted 
cellular attachment ill vitro [Coplen et al., 1991; See et al., 1992; Hyacinthe et al., 1995]. 
Furthermore, it was shown that the cellular attachment to fibroncctin or other ECM-proteins 
could be inhibited by the use of spccifie antibodies (ftbronectin-, 0.5- or BI-integrin 
antibodies), RGD-peptides or various cytotoxic and immunotoxie agents [Pode et al., 19X7; 
Coplen e/ al., 1991; See e/ al., 1992; Hyacinthe e/ al., 1995]. 
III vivo the implantation of intravesically installed bladder tumor cells was studied 
after traumatization of the bladder wall by either cauterization, acid treatment or laser 
irradiation [Soloway and Masters, 1980; Sec and Chapman, 1987a; Sec and Chapman, 
1987b].11/ vi~'u adherence and implantation could be inhibited by intravesical administration 
of heparin, chemotherapy, or RGD-peptides [See and Chapman, 1987; Pan et al,. 1989; 
Hyacinthe e/ al., 1995]. 
In vitro models o/intraepithelial neoplasia 
Up till now only few genu inc models of intraepithelial expansion (lEE) are 
documented. Previously, Rebel et ai, described an in vitro model in whieh a highly-
proliferative, outgrowing edge of a semiconfluent bladder culture was confrontcd with a 
juxtaposed outgrowing sheet of bladder tumor cells [Rebel et al., 1993]. \Ve further adaptcd 
this method to a model that was more comparable with the clinical sihmtion (Figure 5). In this 
improved model of lEE, bladder carcinoma cells are able to implant and may subsequently 
expand into thc normal surrounding urothcliulll [Bindels et al., 1997; chapter 2]. Major 
advantages compared to the carlier model of Rebel et al. arc 1) implantation of bladder tumor 
cells in standardized lesions, which results in confrontation \vith a temporarily regenerating, 
stratified urothelium; and 2) the possibility for accurate quanti Heat ion of lEE. 
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urinary bladder 
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Selective staining of human tumor cells 
+ 
Quantification of tumor area 
Figure 5: xenogel/ie cocultivatioll modelfcJI' the study Of the implantation and subsequent lEE 
a/bladder carcinoma cells. 
Tn another in vitro model, culturing of human bladder carcinoma cell lines on top of 
normal human urothelial stroma resulted in the appearance of an lEE-like phcnotype for some 
ofthe tested cclllines [Booth ef a/., 1997]. 
In vivo models of intra epithelial neoplasia 
Several in vivo stratcgies have been described which gave variable outcomes with 
respect to the formation of intraepitheliai neoplasia (lEN). In rodents, spontaneous formation 
of lEN is not often observed. Exposure of laboratory animals to carcinogenic agents like 
diblltylnitrosamine (DBN), N-blltyl-N-( 4-hydroxyblltyl)nitrosamine (BBN), N-methyl-N'-
nitrosollrea (MNU) N-( 4-(5-nitro-2-t\iryl)-thiazolyl formam ide (F ANFT) and Bracken Fern 
can induce CIS of the bladder [Ito ef a/., 1969; Ohtani ef a/., 1986; Hicks ef aI., 1972; 
Steinberg et al., 1990; Erturk et al., 1967; Bringuier et al., 1995]. However, this procedure 
has major drawbacks, like a high incidence of papillary and invasive tumors, a long lag time, 
toxicity to the animal, possible carcinogenicity to other organs, and an often-observed 
predominance of squamous differentiation [Raghavan et aI., 1986; Oyasu, 1995]. This makes 
these models less attractive as a model of TEN [Hicks and Chowaniec, 1978]. Intravesical 
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administration of these compounds resulted sometimcs in a higher incidence lEN (Summa et 
al., 1984], although these lEN have a squamous differentiation. 
Another approach is xenografting of established bladder carcinoma ccll lines in 
bladders ofim111unodet1cient hosts [Ahlering et al., 19X7; Oshinsky e{ al., 1995; Harabayashi 
et al., 1999]. Originally, thesc studies showed a low yield, because the take of bladder tumor 
cells in intact bladders is largely prevented by an intact bladder surface [Solmvay and 
Masters, 1980]. Therefore, subsequent investigators pretreated the bladder by instillation of 
chemical agents or induced local trauma to promote tumor take [See and Chapman. 1987]. 
Ho\vcver, a major limitation of these procedures is the chance of deep penetration of the 
bladder wall thereby HlCililating tumor invasion [Ahlering, 1987J. To prevent this often-
observed rupture of the basement membrane and its underlying tissues, we designed an 
altemative ill vh'o model of lEN (Figure 6; Chapter 6). Overdislension of the urinary bladder 
of scm (Severe Combined Immunodeficiency Syndrome) mice resulted in pm1ial removal of 
the urothelium. Immediately after partial denudation, suspensions of TCC cells \vere injected 
into the mouse bladder allowing the formation ofIEN. 
Figure 6: Xenogenic in vivo mode/fiJl'IEN A norma/mollse bladder (I) is ol'erdistended by 
instillation a/saline, resulting in partial removal of the 1f1'Othelium, without disruption afthe 
basement membrane and its wu/er()'ing structure (II). Inoculation ofNadder carcinoma cells 
(Ill). Formation (~r lEN (IV). IDark gray: urothelium; Light gray: stroma; Black: hasement 
membrane; Dotted: lEN]. 
Advanced molecular biological techniques, like the generation of knockout or 
transgenic mice can be used to study the effect of specific genes on hlluorigenesis. However, 
a major disadvantage of these methods is the often observed lack for the unambiguous 
determination of gene fbnction in specific tissues, like the bladder. Usage of an urothelium-
specit1c gene construct can circumvent this problem. Recently, Zhang et al. used the organ-
specific expression of Uroplaldn II to induce bladder carcinomas [Zhang e{ al., 1999]. They 
report that mice bearing a 100v copy number of an Uroplakin JI-SV40T tnll1sgene developed 
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carcinoma in situ, \vhereas mice bearing a high copy number developed CIS, invasive tumors 
and metastases. In the future, this Uroplakin 11- or any other bladder-specific promoter can be 
used in vadom: site-specific recombination systems to generate tissue-specific knockout mice 
[Kilby el al., 1993]. A major drawback of the latter approach is that all urotheIiaI cclls are 
targeted and harbor the specific genetical change. Thus, in this model the effect of 
surrounding normal urotheliulTI 011 the formation and subsequent lEE of CIS can not be 
studied. Furthermore, although it is known that the SV40T oncogene can inactivate 1'53 and 
retinoblastoma protein (Blyan and Reddel, t 994), its use will probably circumvent the need 
for other molecular changes of bladder tumorigenesis. In this manner, other relevant genetical 
changes of bladder cancer will not be identified. 
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Determinants of illtracpithclial CXl}ansion 
At present, only few detcrminants of IEE arc known. Theoretically, lEE ,vill be 
determined by the intrinsic features of the hllnor cells and the influence of the host 
environment on the tUIllor cells (see also chapter 7). In the latter case, lEE will probably be 
affccted by the production of paracine growth factors, deposition of ECM-proteins and cell-
cell communication with the surrounding normal urotheliulll. In a prcvious in vitro model, wc 
havc shO\vn that ECM-proteins and growth factors indeed influence the intracpitheliai 
spreading of T24 cells [Rebel el al., 1995]. This could be attributed to a modulation of the 
non~lal urotheliul11 rather than a direct effect of the ECM-proteills or growth factors on the 
hunor cells. 
In our in vUro model, lEE is the outcome of the balance between the expansion of 
bladder tUlllor cells and the regencrative capacity of the surrounding normal urotheliuIll. 
Shifting this balance towards the regenerative capacity of the normal urothelium will probably 
also alter lEE. Investigations into the effects of growth factors on urothelial woundhealing in 
general (Chapter 3) and its effects on cocultivations in particular will contribute to our 
knowledge of lEE. Therefore, we studied whether stimulation of the regenerative capacity by 
epidermal growth nlCtor (EGF) could alter the implantation and subsequent fEE of bladder 
tumor cells (Chapter 2). 
Initial studies identified E-cadherin as a factor intrinsic to the bladder hUllor cells, that 
could influencc lEE. These shldics showed that E-cadherin expression determined the mode 
of replacement of normal urothelium by human bladder carcinoma cells [Rebel et al., 1994a1. 
In this thesis, the specific role of E-cadherin in lEE was investigated in more detail (Chapter 
4). Tn the next paragraphs, the general role of EGF and E-cadherin in bladdcr cancer is 
discllssed in more detail. 
EpMermal growth factor (EGF) 
The EGF-family consists ofa number of related proteins, like TGFa, EGF, amphiregulin, 
epiregulin, hcparin-binding EGF-like growth factor and heregulins [Alroy and Yardcn, 1997]. 
These growth f.1CtorS excri their effect by binding to specific transmembrane receptors, The 
EGF-Iike growth factors bind to erhB-t1mily of tyrosine kinase receptors. The erbB-f.1mily is 
composed of four receptors: erbB-l (also called EGFR or HERl), erbB-2 (also called HER2 or 
Nell), erbB3 (or HER3) and crbB4 (or HER4). ErbBI is the primary receptor for EOF, TOFu 
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and <1mphiregulill, whereas erbB3 and erbB4 are the actual specific receptors for hcregulins 
[Can·away and Cantley, 1994]. 
Several studies emphasize the imp0l1ant role of members of the EOF-family in the nonnal 
or abnOlll1al growth of bladder epithelium [Messing et al., 1987]. F1Il1hermore, EGF is 
implicated in wound healing of the bladder [De Boer ef al., 1994; Rebel ef al., 1994b; Chapter 
3]. Expression of EGF, TUFo. and amphiregulin was found in normal human urotheliul11 
[Kimball et al., 1984; Cilento ef al., 1994] and EGF or TOFu. was detected in the urine of 
respectively healthy individuals [Messing et al., 1987] and bladder cancer patients [Kimball et 
al., 1984]. In non11al human urothelium, EOFR-expression is contlned to the basal cell layer, but 
in bladder carcinomas its expression is seen in all cell layers [Messing et al., 19X7]. Also the 
expression of other members ofEGFR-fami1y is increased in TCC [lmai el al., 1995; Rajkumar 
et al., 1996]. Functional shldies showed that EGF, TGFo: and amphiregulin could stimulate 
proliferation andlor migration ofl1ollnal urothelial cells or bladder carcinoma cells [Rebel et al., 
1994b; Dc Boer ef al., 1996; De Boer ef al., 1997]. 
The E-cadherill-calellin complex 
Cadherins are a family of transmembrane glycoproteins that mediate Ca2+-dependent 
intercellular adhesion [Takeichi, 1990]. This family ineludcs the "classical" cadherins, 
desll1osomal cadhcrins, protocadherins, and products of genes like c-ret and Drosophilia Fat 
[Takeichi, 19931. Cadherins play a well~known role in cell rccognition and cell sorting during 
developmcnt [Takeichi, t 988; Takeiehi, 1991]. In adult organisms they continue to be 
expressed in solid tissucs. The epithelial form of "elassical" cadherins is called E-cadhcrin. In 
epithelium, E-cadherin is necessary for the establishment of tissue integrity and polarity. E-
cadherln is localized in the adherens jUllctions and lateral cell surfaces of epithelial tissues and 
here it forms homophilie cell-cell adhesion complexes. Critical for the function of E-cadherin 
is its intemction with the catenins [Yap el al., 1997]. The catenins link the E-cadherln 
molecule to the actin cytoskeleton (Figure 7). (I.-Catenin possesses an actin-binding activity 
and therefore probably functions by linking E-cadherin to the actin cytoskeleton [Rinllll et al., 
1995]. Normally, ~-catenin is involved in the linkage of the cytoplasmic tail of E-cadherin to 
a-catcnin. However, in experimental settings it was shown that IJ-catenin is dispensable for 
cadherin mediated cell adhesion, as long as a-catcnin is fused directly to cytoplasmic tail of 
cadherin [Nagafuchi el al., 1994]. Together with observations that tyrosine phospOl)'lation of 
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J3-catenin is cOITelated with diminished cell adhesion [Kinch el al., 1995], this suggests that p-
catenin acts as a regulator-site of the cadherin-catenin complex [Gumbiner, 1996]. 
E·cadherin 
Figure 7: 17w E-cadIJel'in-calenin complex. 
Besides its role in cell-cell adhesion, fJ-catenin also participates in the WNT -mediated 
signal transduction pathway [Christofori and Semb, 1999]. Normally, cytoplasmic J3-catenin 
is rapidly phosphorylated by the (APC)·GSK·3p multiprotcin complex and subsequently 
degraded. Cytoplasmic J3-catenin can accumulate if this degradation pathway is not functional 
and the cytoplasmatic tails of E-cadherin arc either saturated or defectivc. In that case, 13-
eaten in can translocatc to the nucleus where a fJ-catenin/TCF transcription complex is formed, 
which can activate the expression of target genes [Nollet el al., 1999]. Although, y-catenin can 
substitute for fJ-catenin in the cadherin-catenin complex, its physiological relevance is still 
unknown [Hiilsken el 01.,1994]. 
Loss of cell-cell adhesion is implicated in the development and progression of human 
cancers [Hirohashi, 1998]. Experimental studies have shown the involvement ofE-cadherin in 
the invasive process. Initial in vitro studies shmved that invasiveness into collagen gel or 
chicken heart tissue was inversely correlated with E-cadherin expression [Behrens el al., 
1989; Frixen et aI., 1991]. Moreover, transfection of E-cadhcrin cDNA into highly invasive, 
E-cadherin ncgative cell lines resulted in a reversal of the invasive phenotype [Vleminckx et 
al., 1991 J. Also loss or impaired function of cutcnins is involved in loss of ccll adhesion and 
the induction of tumor cell invasion ill vitro [Oyama et al., 1994; Vermeulen et al., 1995]. 
Clinical studies revealed that the adhesion fUBction of the E-cadherill-eatenin complex is lost 
during the development of various human epithclial cancers [Birchmcier and Behrcns, 1994]. 
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The role ~f E-cadheriJl-catellin complex in bladder callcer 
In normal urothelium E-cadherin is homogeneously expressed at the cell-cell borders. 
Immunohistochemical studies on the expression of E-cadherin in histopathological material 
demonstrated that aberrant E-cadherin expression correlates with lack of differentiation, 
muscle invasion and metastasis [Syrigos et al., 1999]. Loss of E-cadherin also correlated with 
a decreased recurrence-free and overall survival [Bringuicr et aI., 1993; Syrigos et aI., 1995; 
Liponnen and Eskelinen, 1995; Shimazui et al., 1996J. In addition, abnormal expression of 
catenins or p120cas was also associated with tumor grade, stage, and poor prognosis 
[Shimazui, 1993; Syrigos et ai., 1998a; Sydgos et al., 199Rb]. None of the previous reports 
performed detailed shldies on the E-cadherin immunoreactivity of CIS of the bladder. 
Frixen et aI, (1991) noted that t\vo ill vitro non-invasive bladder carcinoma celilines, 
RTl12 and RT4, expressed E-cadherin, whereas an ill vitro invasive cell line, EJ28, did not. 
Recently, Giroldi et aI, (1999) studied the expression levels of various members of the 
classical cadherins in a panci of 17 bladder carcinoma celi lines. They found that in cell lines, 
which lost E-cadhedn, additional changes in catcnins occurred and that N-cadherin became 
predominantly expressed in these cell lines [Giroldi et aI" 1999}. Hazan et al. proposed that 
N-cadherin promotes the interaction between tumor celis and stromal cells, thereby 
fllcilitating invasion [Hazan et al., 1997]. This suggests that the observed upregulatiol1 of N-
cadherin in bladder carcinoma celilines could be involved in bladder tumor invasion, 
Integrin-Ertracelllllal' matrix interactions 
It has been shown that intraepithelial lesions expand along the basement membrane, 
thereby undermining the normal llrothelium [Murphy, 1994]. The basement membrane of 
epithelia mainly consists of ECM proteins, like collagen type IV and laminin, and 
protcoglycans. The integrins, belonging to the family of cell adhesion molecules (CAMs), are 
the receptors for these ECM-protcins [Hynes, 1992; Ginl1cotti and Mainiero, 1994]. The 
integrin family is composed of 15 (J. and 8 J3 subunits that are contained in to some 25 
different up heterodimeric combinations on cell surfaces. Nowadays, it is \vell recognized 
that integrins are involved in motility, invasion, signal transduction, proliferation, apoptosis 
and angiogenesis [VaIller and Cheresh, 1996; Keely et aI., 1998; Sanders et aI" 1998; Aplin 
el a1., 1999, Ruoslahti, 1999]. 
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Immunohistochemical analysis showed that invasive bladder carcinomas have a 
reduced expression of u.2, 0.3 integrin and an increased expression of a5 integrin (Liebert et 
al., 1994a; Saito e( al., 1996]. Furthermore, Liebert e( al. (1994b) !ound that bladder 
carcinomas exhibited a loss of co-localization between a6B4 integrin and collagen VII. The 
o.6B4 integrin is a component of the hemidesmosomal complex, which anchors the basal 
epithelial cells to the basement membrane [Sonnenberg et al., t 99 t]. Therefore, loss of a6B4 
integrin in bladder carcinoma cells will increase their motility. More recent, Harabayashi et 
al. (1999) showed that reduction of P4 stimulated intraepithelial spreading of CIS on laminin. 
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Scope of the thesis 
A well-known, Imtior problem in the management of supertlcial TCC is the high 
tl-cqucncy of bladder tumor reCUITences. Assuming that these reCUITences belong to the same 
clone as the primaty tumor, implantation and intraepithelial expansion (lEE) of bladder tumor 
cells arc the most likely mechanisms to explain these recurrences. Clinical and experimental 
studies confirmed that this could be the case in most instances. Howevcr, the HlctorS that are 
involved in both mechanisms are only partially understood. 
Therefore! the aim of the studics presented in this thesis was the development of ill 
\'ilro and ill vivo models, that could be useftll in the study of 1) the implantation und 2) lEE of 
bladder h1l11or cells. Subsequently, these models can be used to denne factors that are 
involved in both processes. Both the intrinsic propeliies of the hunor cells and the influence 
of the sUlTot1l1ding urothelium can be studied in these models. 
In chapter 2, a new ill \'itro cocultivation model is dcscribed, in which the implantation 
and subsequent lEE of bladder tumor cells could be studied. A major advantage of this model 
is the possibility for accurate measurements of tumor areas as it expands into the BOllnal 
surrounding urothelium (lEE). In the same chapter, we investigated whether stimulation of the 
regenerative capacity (by EGF) of the traumatized urotheliull1 could counteract TCC 
recurrences. In chaptcr 3, the role of EGF-EGFR family during the regeneration of nonnal 
urothelium was shldied in more detail. Using the previously described cocultivation model the 
lEE capacity of a panel of six different TCC cell lines, with various levels of E-cadherin 
expression was shldicd (chapter 4). Searching for differences/similarities betwcen lEE and 
invasion, ,ve characterized the invasive properties of our panel of TCC cell lines and 
correlated those with E-cadhcrin cxprcssion of the cell lines (chapter 5). To confirm the ;11 
vilro findings on lEE, ill vivo models are required. Chapter 6 describes the establishmcnt of an 
in vivo model of CIS (an intraepithelial neoplasia). 
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Abstract 
A meUor problem in the management of bladder cancer is the high risk for recurrence of 
bladder tumors after transurethral resection. This has generally been attributed to the 
attachment and subsequent expansion of exfoliated hunor cells to the traumatized bladder 
wall. An ill vitro cocllltivation model was used to study the implantation and growth ofhul11an 
tumor cells in traumatized murine urotheliul11. Furthermore, ,ve investigated in a time course 
cxperiment whether stimulation of the regenerative activity of the normal urothelium by a 
growth Hlctor could affect implantation and subscqucnt growth of bladder tumor cells. 
After inoculation on injured confluent cuihIres of murine urotheiiUJl1, human T24 and SD 
bladder carcinoma cells preferentially attached to the denuded areas. SD cells expanded into 
the normal urotheliull1 as a sharply demarcated hnnor, while T24 cells infiltrated as single 
cells. Treatment of the prill1aty urotheliull1 with epidermal growth factor (EGF) stimulated the 
proliteration of the primary urotheliul11 and reduced the implantation and growth of T24 
considerably. EGF reduced the implantation of the SD tumor cells but could not prevent the 
further expansion at the expense of surrounding normal urotheliull1, Since EOP had no effect 
on migration or proliferation of SD or T24 cells, its modulation of expansive growth is 1110st 
probably due to all increase in the regeneration of normal urotheliulll. 
This shIdy suggests that recurrence of transitional cell carcinomas might in some instances 
bc inhibited by stimulation of the regeneration of traumatized urotheliu1l1. The reported in 
\'itro cocultivation model Illay be useful for studying additional factors involved in 
illtracpithelial expansion of carcinoma ceiJs, 
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Introduction 
Human bladder cancer is the fifth most common cancer in males in westem society [I]. Of 
the patients presenting with human bladder cancer, approximately 65% have superficial 
transitional cell carcinomas (Tee). The remaining patients have invasive tumors penetrating 
the muscularis propria and underlying tissue. The patients with superficial bladder cancer 
have a considerable risk of tumor recurrence (up to 70%) and progression [2]. 
Two hypotheses have been put forward to explain TCC reCUlTences. First, on the basis of 
the field cancerization theory, some authors suggested that each recurrent tumor had arisen de 
1I0VO from precancerous flat urothelium [3]. Second, these recurrent hunors may be the 
progeny of a single transformed cell, implying their derivation from residual tumor cells. The 
monoclonality of multiple synchronous or metachronous bladder tumors is strongly in support 
ofthe latter hypothesis [4-6]. 
Several clinical and experimental data indicate that bladder hUllor recurrences could be the 
conscquence of shedding and subsequent reattachment of tumor cells to (traumatized) areas in 
the urothelium [7-10]. In addition, after surgery, residual hU110f cells may cause tumor 
rccurrences at the original site. Thus, two possible mechullisms may underlie recurrences of 
TCC: (1) intraluminal shedding and seeding ofTCC cells on traumatized or intact urotheliull1 
andlor (2) lateral expansion of residual TCC cells into the normal urothelillm. An in vitro 
model is required to shldy the cell biological mechanisms underlying these tumor reclinences. 
Previously wc have shown that murine explant cultures on porous membranes mimic the i1l 
vh'o situation; the culhlfed urothelillm shO\vs multilaycring and differentiation into umbrella 
cells [11]. In an i1l vitro cocultivation model the influence ofECM and growth factors 011 the 
pattern of infiltration of T24 in sUlTounding normal urothelium was examined. Exposure of 
the cultures to acidic fibrobillstie growth fhctor (FGF-l) and laminin led to a significant 
increase in the number of T24 cells infiltrating the normal urothelium, \vhereas epidermal 
growth factor (EGF) and collagen type I and IV counteracted the distance and number of 
infiltrating T24 cells [12]. 
Here, we describe a new xenogenic cocultivation model, which allows more accurate 
measurements of huner areas as it expands into the normal urothelium. This newly developed 
model was uscd to study the implantation and expansion ofhvo human bladder carcinoma cell 
lines: SO, an E-cadherill expressing bladder hunor eelliine derived from a well differentiated 
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bladder hlluor and T24, an E-cadherin negative bladder tumor cell line derived fi'om a poorly 
differentiated TCC [13,14), 
Although under normni circumstances the cell turnover of urothelium is velY low, 
urothelial damage results in a VCly rapid regeneration [15-17]. In nn organotypic mouse 
bladder eulhue model the regenemtion mte of normal urothelium can be stimulated by EGF 
[18, 19J. Addition ofEGF, prior to the induction of the injuries, was used to modulnte the 
implantation and expansion of hUl11nll bladder carcinoma cells. III the case of the T24 cell line 
addition of EGF almost completely inhibited the outgrowth of hllnor cells. This suggests that 
in some instances recun'ence of TCC may be counteracted by intraluminal growth fllctor 
treatment of traumatized lIrothelium. 
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l\'laterials und methods 
Primm)' cultures a/murine lIrotheliu1JI 
Murine urinary bladders were dissected ii'om 6- to 8 \veek-old female C3H1He mice and 
cut into halves. The mucosa was stripped from its underlying muscle layer and spread out on 
a collagen type IV coated eyclopore mcmbrane (Falcon culture-insert, Becton Dickinson, 
Etten-leur, Netherlands) with thc submucosa facing the culhlre supp0l1. Collagen coating \vas 
pcrfonned by incubation of the cyclopore membranes with 25 )1g/ml human collagen type IV 
(Fluka, Oud Bcijerlalld, Netherlands) as described previously [12]. Standard culhlre medium 
consisted of a 1:1 mixture of DMEM and HAM's FLO, supplemented with 10% heat-
inactivated FCS, to ~lg/ml insulin, 5 ~tg/l11l transferrin, 5 ng/ml selenite, 50 nly! 
hydrocortisone, 10 IlM HEPES, 100 JU/ml penicillin, and 100 Ilg/ml streptomycin. The 
explant cultures were incubated at 37°C in a humidified atmosphere of 5% CO2 and grown to 
confluence. 
In some experiments, 20 ng/ml EOF (Sigma, St. Louis, USA) was added to the culturing 
medium 4 days before confluence (±75% confluent) until the cultures were terminated. 
Previous shldies had shown that this dose of EGF optimally stimulates the proliferation of 
mouse urethelial cultures. The medium supplemented with EGF was changed every day. 
Traumatization o/1101'mal mouse urothelillf1l and inoclllation a/h/adder tumor cells 
Injuries were made 2-3 days after confluence. Five circular areas (four peripheral, one 
central lesion) were denuded with a biopsy punch (Stiefel, Offenbach am Main, Germany; 3 
mm diameter). The urothelium in the injured area was scraped a\vay with a glass policeman. 
The advantage of this procedure is that an imprint of the biopsy punch remains visible on the 
membrane and that the injmy can be made in a standardized fashion, allowing the monitoring 
of the boundaries of the circular injured area during the experiments. After injury the -cultures 
were washed twice with PBS followed by inoculation of 105 tumor cells in 1.5 tnl normal or 
EGF -supplemented medium on the murine urothelial explant cultures. The bladder tumor 
cells were allO\ved to attach to the injured areas in the explant cultures for 24 h; next, the 
nonadherent -cells were washed away with PBS and the culhlres were either terminated or 
continued for another 4, 7, or 14 days in normal medium or EGF-supplemented medium. 
Each experiment was performed in duplicate and all experiments were repeated twice. 
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Determination ofprol(j'erative activity 
Two hours before termination of the culture, 40 ~lg/ml BrdU in normal medium was added, 
and the cultures were rinsed twice with PBS and t1xcd in 70% ethanol for at least 24 hours, 
Proliferative activity in normal and injured control cuilures, without tumor cells, on Days 0, 1, 
4, 7, and 14 was assessed by determination of the labeling index (L.I.) and the nuclear 
density, Four areas of 0.15 nun2 around each wounded area were counted. The L.I. is defincd 
as the relative number of BrdU positively stained nuclei in an area of 0, 15 mm2. The nuclear 
density is the total number of nuclei in an area ofO.15 mm2. 
Im1l1uJlohistochemis:{fJ' 
In the case of the BrdU staining, ethanol fixed culturcs were pretreated with 2 M HCI and 
Borax buffer, pH N.5 [20J. Nonspecific binding was blocked with 10% normal goat scrum in 
1% BSA/PBS. Monoclonal antibody RCK 1 08 (Eurodiagnostica, Apcldoonl, Netherlands) is 
specific for human cytokeratin 19 and has no cross-reactivity with mouse urothelium. Almost 
100% of T24 and SD cells are labeled with RCKI08. This feature permits the selective 
identification of human bladder cancer cells in this cocultivation model [21], 
The primary antibodies RCK108 and antibodies against BrdU (Gin of Prof F. Ram<lekers, 
University of Maastricht, Netherlands) were visualized in a two-step peroxidase staining 
method. The sccondalY antibody was horseradish peroxidase-conjugated goat anti~l11ouse 
immunoglobulins (DAKO, Glostmp, Denmark). 3,3-diaminobenzidine tctrahydrochloride 
(DAB) (Fluka), diluted in PBS (2 mg/ml) served as chromogen using 0.03% H20, as 
substrate. Control cultures were counterstaincd in hematoxylin, dehydrated, and mounted in 
Euparal (Chroma, Kongen, Germany). 
Image analysis 
The RCK 108-imll1unostaincd area covered with T24 or SD tumor cells \vithin the normal 
urothelium was visualized with a Hitachi CCTV camera and quantified using KS400 image 
analysis software (Kontron Elektronik, Eelling, Germany; KS400, Version 1.2). RCK108-
stained areas were expressed in square millimeters. In the case of the RCK108-
iml11l1l1ostained T24 cells, a differentiated silver intensification procedure was used to 
enhance the DAB signal [22]. 
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/Hjth),midine illc01poralinn 
To assess the possible growth stimulating effect of EGF on both tumor cell lines, a cell 
kinetic study was performed. T24 or SO cells grown in 75_cm2 culture flasks were washed in 
senull-free medium and trypsinized; lOs cells 'vere seeded in collagen type IV (25 ~Ig/ml) 
coated 96-multi-well dishes (NUIlC, Roskilde, Denmark) and were cultured for 96 h. After 24 
h of incubation in SF medium, various concentrations of EOF diluted in either SF medium or 
standard medium were added. Serum-free medium was similar to the standard medium, but 
without FCS, and supplemented with 0.1 % BSA, 4 ~tM spermine, 4 ~tM spennidinc, 0.1 111M 
ethanolamine and 1 pM putrescine. Proliferative activity was determined at 24, 48, 72, and 96 
h. During the final 16 h of culture, cells were incubated with 0.5 pCi eI-I]thymidine 
(Amersham,'s-Hertogellbosch, Netherlands) per well and subsequently trypsinized and 
harvested. The incorporated (H]thymidine ,vas counted using a BetaPlate scintillation 
counter (LKB-Phannacia, Woerden, Netherlands), and expressed as counts per minutes. 
Cell motWt)' assay 
Chemotaxis was assayed using 48-well microchemotaxis Boyden chambers with 8 ~un 
pore size polycarbonatc Nucleopore fillers [23]. '1'24 and SD cells were passaged by 
trypsinization and plated at a density of Ixl06 cellsllO tnl in 75-cm2 culture tlasks I day prior 
to the assay. Cells were harvested immediately belorc the assay with 2 mM EDTA. EGF (20 
ng/ml) tested as a chemoattractant was diluted in DMEM and added to the lower 
compartment, while the upper compaliment was filled with DMEMlO.l% BSA containing 
25,000 eclls. Human f1bronectin (100 uglml; Sigma) was used as a positiv~ control. Cells 
worc allowed to migrate for 4 h in a CO2 incubator at 37°C. At the end of the assay, filters 
were removed, lixed in cold methanol, treated with RNase and stained with hcmatoxylin. The 
number of migrated cells was counted in a random area of 0.375 111m2 per ,veIl. 
Statistical methods 
A Mann-\Vhitncy U test was used to determine the statistical signilicance of the data 
concellling the attachment of bladder tumor cells on inlact (EGF-stimulated) urothelium. 
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Results 
Regenerative capacity (~l1/o},l1/al or EGF-treated llrathelium 
The injured areas (both peripheral and central) in the nontreated confluent murine 
urothclial cultures were covered within 24 h (Figs. lA, IB and Ie). Since previous studies 
had shown that differences in proliferation existed between the central and the peripheral part 
of the outgrowth of semiconfluent murine explant cultufes [18], regenerative capacities of 
peripheral and centmllesiol1s were evaluated separately. 
A 
, .' 
B 
Figure 1.' TOjJvieU' of primm)' normal 
urotheliwn. Cultures were cOllnterstained with 
hematoxylin. (A) Five i1~;lI1'ies in the urothelilllll 
immediately ({Iier pUNching. (B) At 24 h ({/IeI' 
il/dllction of the b!;ul'ies the denuded areas are 
litlly cOl'ered. Original magnUication 3x. (C) 
Detail (?!' a central lesion covered with 
lira/helium at 24 h q/ter induction a/the hlilfJ)'. 
Imprint of the biopsy punch is jilin!ly visible, 
but is ill another foclls of the microscope. 
OrigillalmagnUicatio1/, 20x. 
Other than a small but consistent decrease of the nuclear density at 24 h after injury around 
both the peripheral and the central lesions in untreated cultures, no further change in the 
nuclear density was seen at different time points (Fig. 2A). Apparently the overall status of 
the control urotheliulll did not change during the 14 day culture period after confluence. The 
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injuries in the further untreated cultures did not lead to a significantly increased proliferation 
(Fig. 2B). \Vithin the regenerated areas BrdU-positivc cells were rarely present. Exposure of 
noninjured and injured confluent urothelial cultures to EGF stimulated the proliferation and 
led to an increase in cellularity of the urothelium compared to that of urothelium not exposed 
to EGF (Figs. 2A and 2B). Again, BrdU positive cells were rarely present within the 
regenerated areas. 
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Figure 2: .Nuclear density al1d Bl'dU incol1JOratioll il11101'1IIal OJ' EGF .. treated iI!jured primm)' 
urothelium (11=6, mean ± SD). Nuclear density and labeling index were not determinedfhl' the 
EGF-treated injured primmy cultures all Days 7 and 14. 
In summary, the peripheral and central injured areas did not reveal a difference in nuclear 
density or labeling index, except for the somewhat higher nuclear density on Day 0 around 
central lesions. The results indicate that in untreated cultures the closure of the injuries, 
without a marked increase in proliferation, can hugely be attributed to migration of cells into 
the injured area. The characteristic decrease in nuclear density at 24 It after injury is in HIVor 
of this explanation. 
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Expamioll ofT24 01' SD on untreated alld EGF-treated ;,?jured llrotheUlllJI 
After seeding of to5 T24 cells on top of the confluent urothelial cultures with five circular 
injured areas, these cells exclusively attached to the five denuded areas. \Vithin 24 h the 
whole lesion WHS covered with T24 cells Hnd regenemting urotheliul11. Strikingly, the 
(RCKto8 positive) T24 cells continued to infiltrate the normal murine urothclium as single 
cells (Fig. 3A). Morphometric analysis of the area occupied by T24 cells in peripheral or 
central lesions sho\ved a slow and gradual increase in the area occupied by T24 tumor cells 
(Figs. 4A and 4B). 
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Figure 3: Topview of (Ill ;,?jured celltral area 
of primm)' urotheUum covered with T24 (A) or 
SD (B) on Day I. (C) TOj1vielV (~r an injured 
central area of EGF-treated lIrotheliuJlI 
co\'ered with T24 on Day 4. T24 cells and S'D 
cells are selectively labeled with RCKI08. 
Original magnification, 1 Ix. 
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SD cells attached primarily to the damaged area of the urothelium, but small colonies of 
SO cells also adhered to the intact urothelium. Twenty-four hours after inoculation, the 
damaged area was tilled with SO cells bordered by regenerating mothelium. A sharp 
demarcation was seen between the normal urothelium and the SO cells (Fig. 3B). No single 
tumor cells penetrating the surrounding nonnal urotheliulll were observed. Morphometric 
analysis of the area filled with SO cells in peripheral or central lesions showed a marked 
increase in time of the area filled with SO cells (Figs. 4C and 40). The increase in SO 
occupied area was more pronounced in the peripheral lesions than in the central lesions. 
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Figure 4: Graphs display the areas occupied by T24 cells in peripheral (A) 01' central (B) 
lesions (~f the urothelium measured 01/ d{flerellt time poillts in 110rmal OJ' EGF-stilllulated 
cultures. Areas occupied hy SD cells ill peripheral (C) OJ' central (D) lesions of the urothelilllll 
measured 011 d{fl'erellt time poinls il1 normal or EGF-slimulated cultures. Data are expressed 
as mean ± standard de\'ialioJ1 (1/=6 cullures). Note the d{flerence ill y-axis hehl'een A and B 
and C and D 
Treatment \vith EGF signiiicrlI1tly reduced the area occupied by T24 eells in both the 
peripheral and the central lesions throughout the whole course of the experiment (Figs. 3C, 
4A and 4B). In comparison with the nOlltreated cultures EGF pretreatment diminished the 
area ofillitial implantation of SD, but did not block the further expansion of SD (Figs. 4C and 
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4D), The reduction of the implantation of both T24 and SD hnnor cells can be explained by 
the stimulation of wound regeneration by EGF, 
Attachment ofT24 and SD cells on intact, EGF-stimulaled 1I1'OtheliuIIl 
It was previously shmvn that E-cadherilHlegative human bladder tumor cells arc not ablc 
to attaeh to intact murine urothclium, in contrast to E-cadherin-positive human bladder hlmor 
cells [9]. Since EGF stimulates multilayerillg but inhibits differentiation into umbrella cells of 
the bladder culhlres [18, 19], we wished to study whether T24 can attach to confluent, EGF-
stimulated urothcliuI11, After inoculation of a suspension of 105 T24 cclls/1.5 IllI no 
attachment to intact untreated or EGF-pretreated confluent murine urothelium was observed, 
EGF stimulation had no significant effect on the implantation of SO cells; 24 11 ancr 
addition of the cells 25.2 ± 14.9 [mcan ± SEM (1/~5)) colonies of SD wcrc observed to be 
attached to the non treated cultures compared to 10,8 ± 5.3 [mean ±SEM (11=5)J colonies of 
SD to the EGF -treated cultures (Mann-Whitney test; P > 0. I). 
E..'{/txt (~rEGF on pro/(teratioll ulld migration ofT24 or SD cells 
To be able to distinguish betwcen the observed direct effects of EGF on the regenerating 
normalurothelium and possible additional effects on thc hlmor cells, we measured the effect 
of EGF on proliferation and/or migration o1'T24 and SO cells. "'hen EGF was added to T24 
or SD cells growing in either senull-free mediulll or standard medium, we could not observe 
any effects 011 the incorporation of eH]thymidinc (results not shown). Migration of the tumor 
cells was measured in a modified Boyden chamber chemotaxis assay. Fibronectin (serving as 
a positive control substancc) stimulated migration of both T24 and SO bladder carcinoma 
cells: 353.7±6,5 T24 cells and 107.0±29,8 SD cells had migrated across the mcmbrane. In 
contrast, EGF did not induce migration of T24 or SD carcinoma cells: in the presence and 
absence of EGF 2,Q±l.O and 3.0 ±t.O T24, respectively, cells were counted on the opposite 
site of the filter. In the case ofSD, the figures were 1.0±1.0 and 2,3±1.0 cells, respectively. 
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Discussion 
With the establishment of the xenogenic in vitro eocultivation model reported hcre we 
were able to study the implantation of bladder carcinoma cells on intact and injured 
urotheliulll) and their subsequcnt expansion. The murine explant cultures mimic the ill vivo 
sihmtion and show the prcsence of multiple layers and differcntiation into umbrella cells. A 
further advantage of this model is that it can easily be manipulated by exposition to growth 
factors and ECM proteins [18) 19]. In a previous eocultivation model of our laboratory tumor 
cells were confronted with the outgrO\ving edge of a nOl1confluent primary explant culture 
[12, 21]. The periphelY of such an outgrowing culture consists of only one cell layer, whercas 
in the ill vilm model reported here the cdge of the denuded area is multilayered. A major 
advantage of the described approach is the possibility of directly visualizing thc expansion of 
tUlllor cells in relation to the surrounding urothelium. The imprint made with the punch during 
traumatization serves as an excellent marker of the originally denuded area. 
After infliction of damage to the confluent mothelial cultures, a rapid regeneration 
occun'ed and the lesions became covered within 24 h. This rapid regeneration was not 
associated with a significant increase in proliferative activity of the urothelium at the edges of 
the injured arcas. This suggests that the regeneration must be due to migration of cells into the 
injured area rather than proliferation. The characteristic and consistent decrease in nuclear 
density at the edges surrounding the injured areas at 24 h is in Hivor of this explanation. 
The high recurrence rate of bladder cancer aftcr tnl11surethral resection of the primmy 
tumor has been attributed to the selective implantation of shedded hunor cells on traumatized 
bladder mucosa [24]. 
The selective colonization of the injured areas after inoculation of T24 and SD cells 
parallels the clinical observations, However) small clusters of SD cells) but not T24 cells, 
\vere also able to attach and colonize intact llrothclium. In a previous study we demonstrated 
the role of E-cadherin expression in this process [9]. Either a homotypic E-cadherin binding 
of the SD cells \vith primary urotheliulll or the E-cadhcrin mediated formation of SD 
aggregates is required for the implantation on intact urothelium. Stimulation of primmy 
urothelium with EGF did not significantly influence the implantation of so cells. Since EGF 
stimulation results in lllurine explant cultures largely devoid of terminally differentiated 
umbrella ceils, this latter cell type does not scem to playa specific role in the attachment of 
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SO to intact urothelium [18, 19]. Further studies are needed to identify the specinc molecular 
mechanisms accounting for the colonization of intact urothclium by tumor cells. 
[nitialIy, after inoculation of T24 or SD cells the injured area occupied by these cells was 
in general smaller than the originally denuded area. Competition with regenerating 
(migrating) primalY urothelium is probably the cause for this effect. After implantation ofT24 
and SD cells to denuded areas in the urolheIiulll, both types of tumor cells were able 10 
expand at the expense of thc primary urothcliulll, but the expansion of SD cells was Illost 
pronounced, pat1icularly in the injured areas in the periphery of the explant culture, where 
nuclear density of surrounding normal urothelium was lowest. Probably in the central 
denuded areas a greater number of normal urothelial cells could migrate tt-om the margins into 
the denuded area, offering more competition with inoculated SO or T24 hUllor cells. 
The implantation and outgrowth of T24 in the in vitro cocultivation model \vas 
counteracted by EOF treatment. EOF stimulates the proliferation, but also the regeneration of 
primaty murine and human urothelial cells in an ill vitro model of bladder regeneration [18, 
19]. In other epithelial cell systems it has been shmvn that EOF can stimulate both cell 
migration and proliferation [25, 26J. FUl1henllore, EGF may induce the synthesis of specific 
extracellular matrix proteins (27]. EOF had, however, no significant effect on the proliferation 
or migration of the T24 carcinoma cells. This lack of responsiveness of T24 cells to EGF can 
perhaps be ascribed to the activating Ras-lllutation [28J in this cell line, which obliterates the 
need for EOF receptor activation. Therefore, the most logical explanation for the observed 
inhibition of the intraepithclial expansion ofT24 cells by EGF is an enhanced regeneration of 
the primaty urothelial cultures. EOF treatment did not influence the intraepithelial expansion 
of SD cells. Since EOF did not affect proliferation or migration of SO cells the capacity for 
intraepithelial expansion of SO cells seems to be an intrinsic property of these cells, which 
enables them to compete successfully with the primary urothelium. 
Cross sections of cocultivation cultures demonstrated that both T24 cells [21] and SO cells 
(data not shown) infiltrate underneath the cells of the normal urotheliul11. This pattern of 
"undermining" intraepithelial expansion resembles the method of expansion of carcinoma in 
situ at the expense of normal urothelium ill vivo [29]. A more effective interaction of tumor 
cell integrins with extracellular matrix proteins of the basement membrane with a higher 
affinity than the interaction of integrins of normal urothelium may offer a possible 
explanation for the lateral expansion of carcinoma in sUu cells. Alterations in integrin 
cxpression protiles by transitional cell carcinoma cells may point to sLlch a mechanism [30, 
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31). Maybe EGF or other growth factors could alter the expression of integrins on nOI1lHlI or 
tumor celis, facilitating the intraepithelial expansion of bladder tumor cells. For instance, EGF 
upregulated cell adhesion and migration of HSC-l carcinoma celis, keratinoeyte migration, 
and regeneration of human ainvay epithelium via an effect on the regulation of integrin 
expression [32-34]. 
Tn conclusion, our data suggest that stimulation of the regeneration of the normal 
urothclium could diminish the implantation of TCe to traumatized areas in the bladder, but 
not to intact urothclium. Further lateral expallsion of implanted tumor cells could be 
prevented in the case ofT24 celis, but not SD cells. 
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Chapter 3 
FUNCTIONS OF EPlDERl\lAL GROWTH FACTOR-LIKE GROWTH FACTORS 
DURING HUl\'lAN UROTHELIAL REEPITHELIALIZATION IN VITRO AND THE 
ROLE OF ERBB2 
E,M.J. Bindels1, Y. IzadifarJ , Th,H. van def Kwast!, D.K. Chopin\ \V.1. de Boer2,J 
IDepar1mcnt of Pathology, Erasmus University, Rotterdam, and 2Depariment of Pulmonology. 
Leiden University Medical Center, Leiden, The Netherlands, and 3Scrvice D'Urologie Hopital 
Henri Mondor AP-HP, EMI INSERNI 99-09, Universite Paris XlI, Crdeil. 

Abstract 
Transitional epithelium of the uril1aty bladder can be damaged during e.g. 
catheterization, overstretching due to obstmcted voiding, or patiial resection. The subsequent 
repair process can be stimulated by specific proteins like epidennal growth factor (EGF) and 
transfonning growth factor-a (TOFa). However, little is known about the role of EGF-like 
growth £.1ctors and their respective receptors in human urothelial repair. In this study, we 
examined effects of EOF, TOFu, 3mphiregulin and heregulin-u. (HROa) on proliferation, 
wound closure, and expression of their receptors c-erbBl to c-erbB4 in primaty cultures of 
human urothelial cells ill \'itro. 
Under conditions representing intact urotheliul11, all EOF-like growth fhctors but HRGu 
induced proliferation. TOFu stimulated proliferation up to four times. Amphiregulin increased 
expression of c-erhB 1. Treatment with either TOFu or amphiregulin resulted in higher c-erhB 1 
activation and c-erbB3 levels. None of the growth Hlctors affected the constitutive expression of 
e-erbB2 and c-erhB4. In the repair model, both EOF and TOFu stimulated the wound closure 
most strongly. This was mainly achieved by increased cellular migration. Receptor expression 
was not affected by exogenous growth factor addition. The role of c-erhB2 in wound healing was 
filliher investigated ''lith the use of antisense DNA. \Vound closure could be delayed up to 50% 
by antisense c-erbB2 but not by mismatched or sense oligonucleotides. 
Excessive production (e.g. in bladder tumors) or application of EOF, TOFa or 
amphiregulin, but not HRGu may lead in vh'o to either hypelplasia or a taster repair of damaged 
urotheliull1. These effects seem to be mediated not only via e-erbBl but also via c~erbB2. Our-
results suggest that modified members of the EOF-EOFR h11l1i1y are potential targets for fbturc 
therapies concerning bladder wound healing and malignancy. 
53 
Introduction 
Normally, the cell tUITIover of bladder epithelium is velY slow [24], but urothelial damage 
e.g. by catheterization, outlet obstruction, deposition of urinmy crystals or partial resection, 
results in a velY rapid regeneration [14]. Urothelial rcgeneration is a tightly regulated process 
involving proliferation, migration, differentiation and extracellular matrix production. Peptide 
growth fhctors arc involved in all of these steps of wound healing. Several studies demonstrated 
that mcmbers of the EOF-family are important mediators of wound healing. The EOF-family 
consists of a number of related proteins, like TOFu., EGF, amphiregulin, epiregulin, heparin-
binding EGF-like growth factor and heregulins [2]. Exogenous application of EOF, TGFo: or 
heregulin stimulates epidennal wound healing ill vivo [7, 12,32]. III addition, EGF and TGFu. 
promote the reepithelialization of the injurcd gastrointestinal tract [29]. 
The EOP-like growth factors bind to erbB-tlnlli1y of tyrosine kinase receptors. The erbB-
family is composed of four receptors: crbB-I (also callcd EGFR or HERl), erbB-2 (also called 
HER2 or Nell), erbB3 (or HER3) and erbB4 (or HER4). ErbBl is the prilllaIY receptor for EGF, 
TOPu and amphiregulin, whereas erbB3 and erbB4 are the actual specific receptors for 
hereguiills [8]. Although a specific ligand for erbB2 is still unknown, c-crbB2 plays a major 
eoordinatOlY role in the erbB-fbmily, because it has the ability to f0l111 heterodimcrs with every 
other erbB-receptor. Also the other members of the erbB-family can fonn hOlllodlmers or 
heterodimers with each other [2]. Dimerized erbB-receptors concomitantly autophosporylate and 
thereby becomc docking sites for proteins bearing SH2 domains, which in hH11 c-ouple to 
dmvnstream signaling pathways [22]. 
The epidennal growth fllctor-family probably plays an imp0l1ant role in the nOllnal and 
abnormal growth of bladder epithelium [26]. Expression of EOP, TGFu and amphiregulin was 
found in norlllal human urotheliulll [9, 25] and EOI' and TOFu werc detected in the urine of 
healthy individuals [26] and bladder cancer patients, respectively [25]. In 110nnal human 
urothclium, EOP-receptor expression is confined to the basal ccll layer, but in bladder 
carcinomas the expression is seen in all cell layers [26]. Also the expression of other mcmbers of 
EOPR-t1Ulli1y is increased in carcinoma of the bladder [23, 30]. Functional shldies showed that 
EOF, TOFu and amphiregutin could stimulate proliferation andlor migration of normal 
urothelial cells or bladder carcinoma cells [16, 17, 31]. Although these shldics emphasize the 
impOliancc of the EOF-family in the 1101111al or abnormal growth ofthc bladder, little is known 
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about the function of EOF-family members and their erbB-receptors in wound healing of the 
bladder. 
Previously, we have shown that EOF can stimulate reepithelialization in an organotypic 
culturc of mouse urothelium [15, 31]. In the present study, an analogous ill vitro model of human 
urotheliul11, which closely mimics ditTerentiation and multilayering of normal urothelium [16], 
was used to investigate the role of members of the EOF-family in nonnal and regenerating 
urotheliul11. Rcsults of our study will be beneficial to the field of bladder reconstnlction and 
replacement surgely. Flilihennore, knO\vledge about the function of the EOF/EGFR family in 
maintenance and repair of nonnal urothclium will also be relevant for urothelial tumorigenesis, 
because growth factors and their receptors can serve as modulators of tumor cell biology, thereby 
influencing tumor grO\vth rate, local invasion and metastasis. 
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Materhtls and methods 
Chemicals 
Biochemicals were obtained as follows: tissue culture additives and EGF (Sigma, st. 
Louis, USA); human collagen type IV (Fluka, Buchs, Switzerland); amphiregulill and HRGa 
(R&D Systems, Minncapolis, USA) and TGFa (Boehringer Mannheim, Mannheim, Gennany). 
Previously, effective concentrations of these ligands were determined by constnlction of dose-
respons curves [17]. Antibodies were purchased as follows: anti c-erbBl (Oncogene Research, 
Uniondale, USA); anti phosphOlylated c-erbBl (Transduction Laboratories, Lexington, USA); 
anti c-erbB2 and secondary antibodies (DAKO, Glostl1lp, Denmark); and anti c-erbB3 and anti 
c-erbB4 (Santa Cruz Biotechnology, Santa Cruz, USA). The anti-BrdU antibody was kindly 
donated by Dr. B. Schutte (University of Maastricht, Maastricht, The Netherlands). 
Cell Cullure 
Primary human explant cultures were established as described prcviously [16} Briefly, 
fresh and macroscopically normal appearing ureter specimens were obtained fi'o1l1 resection 
material frol11 paticnts treated for non-malignant renal diseases. The urolheliul11 was stripped 
from the submucosa and proccssed onto cyclopore membranes (Falcon culture inselts, Becton 
Dickinson) coated with collagen type IV (25 ~1g/1l11). Primary explant cultures were obtained 
using DMEM/Ham's F12 medium supplemented with 5 ~Ig/ml insulin, 5 ~Ig!ml transfelTin, 5 
ng/ml selenite, 5 nM hydrocoltisone, 10 Illlv! HEPES, 2 lluVI glutamine, 100 IV penicillin, 100 
pglml streptomycin, and 10% heat-inactivated FCS. This medium is refelTed to as routine 
mcdium. Olltures were incubated at 3rC in a humidified atmosphere of 5% C02 until 2 weeks 
post-contlucncy. Twenty four hours before the sImi of an experiment, the remaining explant was 
removed and culture mediulll \vas replaced with routine mediulll devoid of insulin and FCS, but 
supplemented with 0.1% bovine senUll albumin, 4 ~IM spelmine and spe1111idine, and I ~IM 
ethanolamine (refelTed to as scmm-tiee medium [SF]). Experiments were performed in SeI1I1TI-
fi'ce medium. 
C0I1fluent cultllre model mimicking intact /fro/helium 
AHer reaching contluency, cultures were maintained in routine mcdiulll for an additional 
two weeks to ensure proper differentiation of the whole cuihlrc. Before treatment with growth 
factors, cultures \vere rinsed twice \vith SF followed by incubation in SF for 24 hours. 
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Subsequently, medium was replaced with SF with or without grO\vth fhctor for another 96 hours. 
Nlcdium was replaced daily during the course of the experiments. 
Culture model mimicking reepitheliaUzing urothelium 
Injuries were made directly after the 24~hours incubation with SF. Four circular 
imprints were made v-/idl a biopsy punch (Stiefel, Offenbach am Main, Gcrmany; 0 4mm) 
[61. The urothelium within the injured areas was scraped manually under a dissecting 
microscope, After injmy, the culhlres were ,vashed hvice ,vith SF followed by incubation of 
the cultures with SF with or without the addition of growth factors. At different time-points 
during cultivation, the wound edge was monitored through a light microscope. From the 
acquired image, the uncovered area was measured and expressed as percentage of the initial 
wound area. 
In the experiments, where the de 1/01'0 c~erbB2-protein production was blocked using all 
antisense oligonucleotide strategy, 24 hours before damage, routine medium was replaced with 
SF containing 5 nmol/ml oligonucleotides. After 24 hours, damages were made as described. 
During the next 48 hours, medium with our without oligonucleotides was replaced twice. 
Phosphorothioatcd oligonucleotides were obtained in collaboration with Dr. M. Lcmuitre 
(Eurogentec, Liege, Belgium) based on experiments described by Vaughn et al. [35]. Sequences 
of the respective C-erbB2 oligonucleotides arc: antisense oligonucleotide: 5'-
GAGGTACCACGAGTG-3'; mutated variant of the antisense oligonucleotide: 5'-
GAGTGACCACAGGTG-3'; sense oligonucleotide: 5'-CTCCATGGTGCTCAC-3', 
Prol((eratioll assay 
Two hours before tenninatioll, cultures were incubated with 40 ~lg/llli 
bromodeoxyuridinc (BrdU). Subsequently, culhlres were rinsed with PBS, pH 7.2, and tlxed 
with 70% ethanol follO\ved by immunohistochemishy. Eight prefixed areas of O.l5nun2 per 
culture were counted. Four areas just outside each wound and another four areas within the 
wound that were covered by regenerative urotheliulll were counted. The BrdU-incorporation was 
expressed as the labeling index: the relative number of BrdU~positive nuclei in four prefixed 
arcas of0.15nun2 per culhlrc. 
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IIJIIJIIIJlohistochemistJ), 
The i111111UI1ostaining of thc cultures was pcrformcd as dcscribcd [16]. Thc expression 
was visualized using appropriate dilutions of the primary antibodies in a conjugated 
il11l11unoenzyme assay. SecolldalY antibodies were either peroxidase or alkaline phosphatase 
conjugated. As substrates, we used 3,3' -dial11inobenzidine tetrahydrochloride or naphtol AS-
MX phosphate. The level of c-erbB-reccptor expression was determined semi-quantitatively, 
with 0 = no expression; I = low expression; 2 = moderate expression; 3 = high expression; 4 
= very high expression [14], 
Statistics 
Experiments were perfoll11ed at least in triplicate. A student's Hest was used to 
detennine the statistical signif1cance of the data. At p<O.05, data were accepted as 
statistically significant. Data are represented as mean ± standard elTor. 
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Results 
Confluent cultures representing intact urothelium 
As shown in Figure lA, treatment with amphiregulin and TOFa, signif1cantly 
enhanced the proliferation of the urothelial cultures three to four times as visualized by the 
labeling index (p<O,Q03), In contrast, treatment ''lith HRGa or EGF did not stimulate 
urothelial proliferation. The cellularity of the cultures is increased upon treatment with 
amphircgulin, TGFn or EGF (Fig. lB). The lact that EGF induccs an enhanced cellularity of 
the cultures must imply that EGF had transiently stimulated proliferation before the addition 
of BrdU or that EGF could inhibit apoptosis in these urothelial cultures, as has previously 
been described for other cell cultures [I I, 21, 34]. 
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The amphiregulin and TGFa mediated induction of proliferation is associated ,vilh an 
enhanced expression of c-erbB3. The constitutive expression of c-erbB2 and c-erbB4 V·/aS not 
changed upon growth faclor treatment. The constitutive expression of c-erbB I was only induced 
by amphiregulin, whereas the expression of phosphOlylated c-erbB I was slightly enhanccd by 
both amphiregulin and TOFa (Fig. IC). 
Given the upregulation of both phosphOlylated c-erbBI as well as c-erbB3 by 
amphiregulin and TOFa, it is tempting to hypothesize that amphiregulin, EOF, or TOFa mediate 
their eftccts also via c-erbB3. FUl1hennore, the expression of c-erbB4 in the intact cultures is 
constitutively high itTespective of the growth illCtor treatment, and it is known that c-erbB3 has a 
high affinity for c-erbB4 to fonn a heterodimer [8], However, HROa, which primarily signals 
through the c-erbB3/c-erbB4 heterodimcr, has no proliferative effect on human urothelial cells 
(Fig. IA). 
Regenerating urothelial cultures 
Under SCHull-free conditions, approximately 84% of the wounds is covered with new 
urothelium within 48 hours, The reepithelializcd area is markedly enlarged upon treatment 
with TOFa or EGF, and to a lesser extent, by amphircgulin (Fig. 2), In fact, ,vhcn treated 
with EGF or TGFa, wounds completely closed \vithin 48 hours. Treatment with HRGa has 
no effect 011 urothelial regeneration as comparcd to nontreated cultures. 
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Figure 2: h1f/uence of EGF-like growth factors 011 reepithelializafion (!f'il[jured lll'othelial 
cultures. 
In general, growth factor treatment has no stimulating effect 011 urothelial proliferation 
during the f1rst 24 hours of wound healing (Figs, 3A and 3B). During the next 24 hours, a 
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In general, growth factor treatment has no stimulating effect on urothelial proliferation 
during the t1rst 24 hours of wound healing (Figs. 3A and 3B). During the next 24 hours, a 
gradual increase in proliferation was noted. Nevertheless, labeling indices remained relatively 
low. Therefore, the observed stimulation of reepithelialization after EGF, TGFu or 
amphiregulin treatment could not be explained by a significant induction of proliferation. 
This suggests that the induced rcepithelialization could only be explained by an enhanced 
migration of cells into the denuded area. 
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Figure 3: Eflect o/EGF-like growth/ilctors 011 the prol(lerotion o/illillred lIrothelial cultures. 
BrdU inc()}]JOmtioll was determined i11 prejlxed regions (A) jllst out.\·ide the b!iUl)' and (B) 
witMn the reepithelialized wound-area. 
The stimulated wound closure may be accompanied by an enhanced expression of 
specific growth nictor receptors. According to other functional studies, EGF-Iike factors mediate 
their effects mainly via c-erbBl, c-erbB2, and c-erbB4. Therefore, we quantitatcd the 
immunohistochemical expression of c-erbB 1, c-e1'hB2 and c-erhB4. The c-erbB I expression is 
low and is not significantly affected by any of the investigated growth illCtors during any point of 
the repair-process (data not shown). The c-erbB2 expression tends to be higher only in cells near 
the edge of the damaged area upon treatment with amphiregulin, TGFa or EGF (Figs. 4A and 
4B). The e-erhB4 expression shows no significant differences during wound healing (data not 
shown). 
Gur data points to a tlmction of not only c-erhB 1, but also of c-erhB2 in the epithelial 
regeneration. To investigate whether e-erbB2 is necessary for the reepithelialization, we treated 
cultures with antisense oligonucleotides for c-erbB2 and examined the regeneration during this 
treatment. 
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Figure 4: EYjJl'essirm (~r c-erhB2 ill EGF-like growth factor treated injured lff'OIhelial 
cultures. C-erB2-e.ypressioll was determined at various time-points ill regions (AJ jlls! olltsMe 
the iI!iwy (fnd (B) within the l'eepithelialized WOl/lld area. 
Tl'eatlllellf o/illjured cultul'es witll c-el'hB2 autisellse DNA 
Treatment of damaged cultures \vith c-crbB2 antisense oligonucleotides significantly 
inhibited the reepitheIiaIization up to 50% (Figs. 5 and 6A). The sense and the mismatched 
variant of the antisense oligonucleotides did not affect the regeneration (Figs. 5, 68 and 6C). 
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Figure 5: Influence of c-erhB2 oligonucleotides Oil the reepithelializatioll of injured 
urothelial cliitures. 
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Figure 6: Topview 0/ standardhed fI!illries made ;'1 prinuu:)' cultures of hUl11an urotheliwn. 
Efleet 011 reepithelializatiol1 aper treatment for 24 hours lI'ith c-erbB2 oligoNucleotides: (A) 
antisense DNA, (B) sense DNA and (C) nlutated variant afantisense DJ.lA. 
This indicates that the wound healing was specifically pcrturbed by the c-erbB2 
antisense only. The proliferation was similar in all damaged cultures (Figs. 7A and 7B) 
suggesting that this delay in reepithelialization could not be explained by a diminished 
proliferative capacity of the antisense treated cultures. Also, none of the control 
oligonucleotides had a significant effect 011 proliferation. 
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Figure 7: E/leets (~f c-erhB2 oligollucleotides 011 the BrdV inCOIporatioll, determined (A) just 
out.'.ide the b!iuries and (B) within the reepithelialized area. 
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Discussion 
Earlier studies on the functional effects of EGF-Iike growth i1lctors on urothe1iul11 are 
conflicting, Previollsly, we have shown that the growth and regeneration of murine urothelium ill 
\'itro was stimulated hy TGFu or EOF [6, 15,31]. Furthenl1orc, ill vivo studies indicated that 
EGF induced urotheliai proliferation and hypel1)iasia in rats and pigs [26, 37], However, others 
have claimed that despite thc presence of EOF-rcccptors on human urothelium [16, 27], EOF 
was not essential for the grO\vth ofnonnal human urothelial eclls ill vitro [9,20,27, 33}, 
In this study, using II previously described in vitro organotypic model for IllUlk'm 
urothelium, amphireguiin, TOFu anel EGF stimulated thc growth of intact human urothcliul11, 
No functional effects of amphiregulin on the growth of human urothclium have been reported 
previously, But Cilento et aI, showed that human urothelial cells in culture can producc high 
levels of amphiregulin mRNA, suggesting that amphiregulin is involved in the autocrine gro\\1h 
regulation ofurotheliulll [9], 
\Ve demonstrated that urothelial reepithelialization is enhanced by the EGF-like fhctors 
TGFa, EGF and amphiregulin but not by HRGa, The mode of action of TGFa.lEGFI 
mnphiregulin may be mainly through interaction \\'ith EGFR which either transduces thc signal 
by homodimerization or by heterodimerization with c-erhB2, Treatment of the regenerating 
urothelial cultures with c-erbB2 antisense DNA confirmed that c-erhB2 might be involved in 
urothelial regeneration, The role of c-erbB3 during the EGFITGFa/amphiregulin stimulated 
rcepithelialization is not yet clear as these illctors do not hind to c-erhB3. Though, 
heterodimcrization of c-erbBI or c-erbB2 with c-erbB3 may attribute to the observed effect [I, 
28], An alternative role for c-erbB3 is that endogenously expressed HRGu may stimulate the 
proliferation in a c-erbB3-dependent way, Fm1hermore, the constitutive high expression of c-
erbB4 during urothelial reepithclialization is suggestive for a role of c-erhB4 in urothelial 
maintenance andlor regeneration, Future flmctionai ill \'ilro studies may clarify possible 
fimctions of these respective EGFR f.11l1ily members in urothelial regeneration, 
In the same model of urothclial regeneration, Daher e{ aI, recently showed that 
rcepitheliaiization could also be inhibited hy a functional blocking EGFR antibody or by the 
EGFR-tyrosine kinase inhibitor Tyrphostin AGl478 [10]. In their study. these EGFR inhibitors 
al1ected both proliferation and migration in urothelial 'VOlUld repair, Our combined data indicate 
that in damaged urothcliul11 both EGFR and c-erhB2 are involved in the process of 
reep i thel ializa ti on. 
Our experiments with the antisense c-erbB2 oligonucleotides suggest that c-erbB2 is an 
impor1ant mediator of migration during wound healing. Few studies reported on the role of the e-
erbB2 protcin in cell migration. Overexpression of c-erbB2 in breast or ovarian carcinoma cells 
or fibroblasts resulted in an increased cell migration [18, 36] or invasion [13]. FUl1hennore, 
cytoplasmatic expression of pl8S-neu in human astrocytoma cells is associated with a high 
degree of migratory activity [5]. The exact mcehanisms of c-erbB2-enhanced migration are only 
poorly understood. A direct mechanism could be via signaling through the Ras-MAP kinase 
pathway [31 ultimately leading to transcription of gencs involvcd in cell migration. Indirectly, it 
may be caused by downregulation of E-cadherin or a.2-integrin [19] or by activation of the PEA3 
transcription factor that in hml activates genes, which encode enzymes required for cell 
migration [4]. 
In conclusion, the EGF-EGFR pathway is involved in the nOllnal growth and 
regeneration of human urotheliulll. Amphiregulin, EGF and TGFu. might be involved in the 
(autocrine) growth regulation of urotheIiul11. Enhanced expression of some of these growth 
factors and their receptors could contribute to the deregulated growth of bladder hunors, making 
them suitable as targets for tllture developments ill cancer therapy. On the other hand) EGF and 
TGFa are imp0l1ant mediators ofrccpithelializHtion, suggesting that concise use ofEGF~fami1y 
members could aid regeneration of damaged urothcliulll, and improve bladder reconstl1lction and 
rcplaeclllent surgery. 
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Abstract 
High-grade transitional cell carcinomas (Tee) of the urinary bladder arc frequently 
associated with carcinoma ill situ, which may replace large areas of the mucosa of the llrinary 
tract. The invasive component of Tee often reveals a loss of expression of the cell-cell 
adhesion molecule E-cadherin, but the role of E-cadhcrin in the development and expansion 
of intracpithelial neoplasia is unknown. To study the underlying mechanism of intracpithelial 
expansion we have developed an illtraepithelial expansion (lEE) assay. Human Tee ceUtines 
were investigated in this lEE assay for their capacity to replace the SUlTOllllding 110l1nal 
murine urothelial cells. 111 vitro lEE appeared to be prominent in three (SD, RT112, and 1207) 
of the four E-cadherill positive cell lines. Although the two E-cadherin negative cell lines 
(T24 and J82) were able to penetrate surrounding nonnal llrothclium as single celis, they 
largely lacked the capacity of lEE. These results prompted liS to investigate whether the coll-
cell adhesion molecule E-cadherin is an imp0l1ant detenninant for IEE. T24 cells transfeeted 
with full-length mouse E-cadherin eDNA, displayed an enhanced intraepithcliai expansion 
rate. Transfection did not influence their proliferative capacity, or their pattern and level of 
integrin expression, or their ability to expand in the absence of surrounding urothelilllll. The 
data suggest that E-cadherin mediated cohesiveness is an imp0l1ant factor in the 
intraepithelial expansion of bladder carcinoma cells. These observations argue for a dual, 
paradoxical role of E-cadherill in bladder tUlllorigenesis. On the one hand, E-cadherin 
promotes the expansion of intracpithelial neoplasia; on the other hand, its loss correlates ,,,ith 
invasive behavior. 
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Introduction 
High-grade transitional cell carcinomas (TCC) of the urinary tract are frequently 
accompanied by carcinoma ill situ (I). Carcinoma ill situ of the urinmy tract is characterizcd 
by the replacement of the normal lining urothelium by dysplastic cells, which show a variety 
of cellular and molecular changes. Carcinoma ill situ may rcplace large areas of the urinmy 
tract mucosa, extending evcn to the urethra and - in males - to the prostatic ducts and glands 
(2). In general, carcinoma in situ is regarded as a precursor lesion for invasive bladder 
carcinoma (3). 
Patients with carcinoma in situ in the flat peripheral urothelium adjacent to tumors have a 
higher probability of tumor recurrenccs andlor invasion (4,5). Clinical and experimental data 
suggest that bladdcr tumor recun-ences could be the consequence of intraepitheliai expansion 
of the transformed cells fi'om the original tumor or shedding and subsequent reattachment of 
bladder tumor cells paliicularly to traumatized areas in the bladder mucosa (6-11). Lateral 
expansion of the attached tUlllor cells can then lead to the replacement of normal urothelium 
by cancer cells. The mechanisms involved in lateral (i.e, intraepithelial) expansion of bladder 
tumor cells are only partially understood. A cocultivation model established recently in our 
laboratory permits the direct visualization of attachment and subsequent intra epithelial 
expansion (lEE) of bladder tumor cells at the expense of surrounding normal urotheliul11 
(10, II). In this assay, a hunor cell suspension is inoculated on confluent mouse urothelial 
cultures containing de~epithelializcd areas of a standard size. Implantation of tumor cells 
occurs predominantly in these de-epithelialized areas and the time course of lEE can be 
assessed by selective immullostaining of the tumor cells. Previously, we have shown in this 
model that exposure to growth factors and culture on substrates coated with particular 
extracellular matrix protcins could influence lEE (t 0, 11). 
E-cadherin is a member of a family of transmembrane glycoproteins involved in 
intercel1ular adhesion. E-cadherin function is mediated by the interaction with the 
cytoplasmatic u.~, p- and y-catenins. These catenins connect E-cadherin with the cytoskeleton. 
In model systems, loss of E~cadherin expression is associated with the gain of the invasive 
phenotype in tumors (12-14). Similarly, it \vas reported that loss of the invasion suppressor 
molecule E-cadherin or catenins is associated with deeply invasive bladder cancer and is 
predictive for poor survival of patients with bladder cancer (15 M I 7). The E-caclherin/catenin 
complex also contributes to a variety of physiological functions like cell growth, 
74 
differentiation, wound healing, cell motility, morphogcncsis, and organogenesis (IS). 
However, its role in the expansion of carcinoma in situ of the bladder has not yet been 
studied. 
In this study, initial experiments comparing EHcadheril1~positive and -negative human TCC 
cell lines suggested a potentially enhancing role of E~cadhcrin in lEE. By use of T24 cclls, 
stably transfected with an E-cadherin eDNA construct, we could confinn that this molecule 
indeed contributes to lEE most likely by conveying increased cohcsiveness to the Tee cells. 
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1\'1atcrial nud methods 
Cell culture 
Thc human bladder cancer cell lines T24, SD, RTlI2, JON, and 182 were kindly 
provided by Prof. Dr. lA. Schalkcn (Urological Research LaboratOlY, University Hospital 
Nijmegen, The Netherlands) and have been characterized previously (19,20), Human bladder 
carcinoma cell line 1207 was obtained from Dr. \V,1. De Boer (GETU Service d'Urologie, 
Paris, France; Ref. 21). Cell lines were maintained in the same standard medium as the 
primary bladder explant eulhlres. 
PrimalY e.\plant cultures a/Il/urine urotheUum 
Murine urinary bladders were dissected from female C3H1He mice, 6-& weeks of age, and 
cut into halves. The mucosa of the bladder was stripped fi'om its underlying muscle layer and 
subsequently spread on a collagen type IV (25 Jlg/ml human collagcn type IV)-coatcd 
Cyclopore membrane (Becton Dickinson Labware, Bedford, USA) with the submucosa t:1cing 
the culture suppOli. Standard cuihlre medium consisted of a I: 1 mixture ofDMEM and Ham's 
FlO, supplemented with 10% heat-inactivated FCS, 10 ~Ig/ml insulin, 5 ~Ig/ml transferrin, 5 
ng/ml selenite, I 0 ~IM HEPES, 50 nM hydrocortisone, 100 IU/ml penicillin and 1 00 ~lg/1l11 
streptomycin. The explant cultures were grown at 37° C in a humidif1cd atmosphere of 5% 
CO2, These murine explant cultures on porous membranes mimic the in vivo situation; the 
cultured urothclium shows a polarized multilayering and differentiation into umbrella cells 
(22). 
intraepithelial e.\pansioJI (IE1.) assay 
The cocultivation model to study lEE of bladder carcinoma cells was described previously 
(II), Briefly, in confluent murine expJant culhlres four standardized circular areas were 
denuded in the periphery of the primmy cultures by cautious imprinting with a 3-m111 dicuneter 
biopsy punch (Stiefel, Offenbach am Main, Germany). The urothelium in the injured areas 
was scraped away from the cyclopore membrane with a micropipette tip. Subsequently, the 
cultures were washed hvice with PBS, followed by seeding of 105 tumor cells in 1.5-1111 
standard medium on the murine urothelial explant cuihnes, The bladder tumor cells were 
allowed to attach to the injured areas in the explant cultures for 24 hours; nonadhcrcnt cells 
were then washed away with PBS, and the cuI hires were either tel1uinated or continued for 
76 
another 4, 7, or 14 days in standard medium, Each experiment was performed twice in 
triplicate, The cultures were terminated by fixing them in 70% ethanol and stored at 4°C until 
immunohistochemistry for selective identification of the human bladder carcinoma cells was 
performed. 
Monoclonal, human-specific antibodies, RCK 108 (Eurodiagnostica, Arnhem, The 
Netherlands) or DC 10 (Beckman Coulter, Fullerton, CA, USA), directed against cytokeratin 
19 were used to distinguish the human bladder carcinoma cells from murine urotheliull1 (10), 
Monoclonal antibody DClO was used for staining 182 cells, whereas the other cell lines \vere 
stained with monoclonal antibody RCKlO8. Nearly 100% of the bladder carcinoma cells of 
each cell line was labeled with RCK I 08 or DC 1 O. The secondary antibody was horseradish 
peroxidase-conjugated goat anti-mouse immunoglobulins (Dako, Glostrup, Denmark). 
Peroxidase activity was visualized with 0,03% H20 2 and 0,02% 3,3,-diaminobenzidine 
tetrahydrochloride (Fluka, Basel, Switzerland) diluted in PBS. 
The immullostained areas were quantitated with a Hitachi CCTV camera equipped with the 
KS400 image analysis sofhvare package (Kontron Elektronik, Eehing, Germany), and 
expressed in 111m2, 
Construction of.s·table tra't~/eclallls 
The E-cadherin-negative cell line T24 was cotransfected with plasmids pBATEM2 and 
pSVneo, which harbor the neomycin resistance gene. Marion Bussemakers (Urological 
Research Laboratory, University Hospital Nijmegen) generously provided plasmid 
pBATEM2, containing the full-length mouse E-cadherin eDNA, originally constructed by 
Nagafuchi et al.(23), For lransfection, cultures were cotransfected with a total of 20pg of 
DNA (pBATEM2: pSVIlCO, 20:1) using the DNA-c.lcium phosphate method (24), and 
transfcctcd cells were selected with 800 pg/ml 041 g, E-eadhcrin expression in these 
transfected eell lines was detected as follows, Clones were grown to confluence on 
multiehamber slides (Nunc, Naperville, USA) and fixed in methanol at -20°C, Cells \vere 
incubated overnight at 4°C with monoclonal antibody DECMA-I (Sigma, St. Louis, USA), 
followed by a biotinylated rabbit anti-rat immunoglobulins (Dako) and fluorescein-conjugated 
streptavidin (Dako). The different clones retained their resistance to G418 and were stable in 
their E-cadhcrin expression during the entire course of the described experiments. 
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Flow cytometl'ic ana~)'sis ofE-cadherill and integrin e.\pressioll 
Cells were harvested by a short trypsinization of contluent mono]ayers. Cell suspensions 
were made in PBS containing 0.5% BSA, 0.1% NaN3, I 111M CaCb and 0.51111\11 MgCb at a 
concentration of 1 x ron cellsll11l. E-cadherin expression of a selection of nine different, 
transfected T24 clones was examincd with the DECMA-I antibody, followed by biotinylated 
rabbit anti-rat immunoglobulins and fluorescein-conjugated streptavidin. Integrin expression 
,vas studied with the use of specific antibodies against al-integrill (HP2B6, Beckman 
Coulter, Fullerton, CA, USA) a2-integrin (NCL-CD\V49b, Novacastra, Newcastle upon 
Tyne, UK), a3-integrin (NCL-CDW49c, Novacastra), a4-integrin (P4G9, Dako), a5-integrin 
(PID6, Dako) u6-integrin (NCL-CDW49t: Novacastra), pl-integrin (TDM29, Sanbio, Uden, 
The Netherlands) and p3-integrin (NCL-CD61, Novaeastra). As a negative control, the 
primary antibody was omitted and replaccd by a PBSIBSA/Azide solution. Data acquisition 
and analysis were performed on duplicate samples on a F ACScan flow cytometer using 
CELLQuest software (Becton Dickinson, San Jose, CA, USA). 
lmmunoblotting 
Confluent cultures were lysed in 2X sampling buffer [4% SOS, 200 mM DTT, 
100mM Tris (pH 6.8), 20% glycerol, and 2% Triton X-IOO], and equal quantities of protein 
(30pg) were run on a 7.5% SDS-PAGE. The IvIDCK cell line was used as a positive control 
for E-cadhcl'in expression. After electroblotting, blots were imll1unoslained with the DECMA~ 
I antibody, followed by biotinylatcd rabbit anti~rat immunoglobulins. Next, <1n alkaline 
phosphatase-conjugated streptavidin label (Biogenex, San Ramon, USA) was applied. Finally, 
bound antibody was visualized by histochemical staining with NBTIBCIP ([nitro blue 
tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate toluidine salt] Roche Diagnostics, 
Basel, Switzerland). 
111 \'itro ill\'Gsioll assay 
Chicken heart invasion assays were performed as described by Marcel et al. (25). Briefly, a 
selection of E-cadherin transfected T24 clones was contl'onted with precuitured rounded 
fragments of cmbryonic chicken heart 011 soft agar for 24 hours. Next, fragments with 
attached bladder tumor cells were kcpt in suspension culture under gyrotOlY slHlking (120 
rpm; 37°C; 5% CO2) for 6 days in MEM REGA 3 mcdium (GibcoBRLI Life Tecllllologies, 
Breda, The Netherlands) containing 10% FCS. Fragments were fixed in 4% phosphate 
buffered formalin and embedded in paraffin. Invasion was scored on serial histological 
sections stained \vith hematoxylin/eosin. The tumor cells were distinguished from the heart 
tissue by their morphological feahlres. 
Wound c%n;zatioll assay 
T24 Clones were grown to confluence in 10-cm 0 culture dishes. \Vith a plastic 
pipette tip, cells were scraped away in the shape of a cross. The width of the lesion was 
approximately 5nun. After 16 hours the movement of cells into the wound was monitored and 
photographed. 
E\pansion ofT24 clones on collagen type IV-coated cyc!ojJore membranes 
\Vith a 3-111111 0 biopsy punch (Stiefel, Offenbach am Main, Germany), a superficial 
circular imprint was made on the cell culture inserts, coated with collagen type IV. A cell 
suspension of 105 eellsl2~tl standard medium was pipctted within the borders of the circular 
imprint with a 1 O-~tl micropipette. The cells in the drop of medium attached into the circular 
area within 24 hours. Every two days medium 011 top of the membranes was refreshed, taking 
care that the medium only covered the area of tumor cells. l'vfedium underneath the membrane 
was refreshed twice a week. The circumferences of the outgrowing sheet of tumor cells were 
drawn daily. From these drawings, the arca (mm2) of outgrowth was determincd. 
[3 HJThYl1lidill illCOIporatioll 
To assess the potential differences in proliferation of the different T24 clones, a cell kinetic 
study \vas performed as described earlier (II). Briefly, T24 clones grown in 75 cm2 cu/hlre 
flasks were synchronized in senun-free culture medium for 24 hours. Subsequently, 105 
cells/well were seeded in collagen type IV-coatcd 96-wells dishes and were cultured in 
standard medium for 4 consecutive days. Proliferative activity was determined at 24, 48, 72, 
and 96 hours. During the final J 6 hours of culture, cells were incubated with 0.5 ~tCi 
CH]thymidin/wcll. The incorporated eH]thymidin in harvested cells was counted in a 
BetaPlate scintillation counter (LKB-Phannacia, \Voerden, The Netherlands). 
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Results 
lEE a/human hladder carcinoma cells 
The lEE of a panel of six different Tee cell lines V·/aS studied, After the seeding of 
tumor cells on wounded confluent murine urothelial cultures, the tumor cells preferentially 
attached to the dc-epithelialized areas. \Vithin 24 hours, these areas ,vere covered both by 
tUlllor cells and regencrating urothclium. Control experimcnts showed that in the absence of 
inoculated tumor celis, the dc-epithelialized areas became entirely covcred by regenerating 
llormal urothelial cells within 24 hours (11). The areas covered by tumor ccUs at 24 hours 
were of the same size for four of the six examined tumor ceUlines, but implantation of JON 
or J82 cells was less effective. As described previously, E-cadherin cxpression inlluenced the 
pattern of lEE (10,11), Bladder tumor cell Iincs with no (T24 and J82) or a hctcrogeneous 
(1207) expression of E-cadherin were able to infiltrate the sUITounding normal urothclium as 
single cells (Fig. I A). whereas bladder tumor cell lines with 11 homogeneous (SD, RT 112. and 
JON) expression of E-cadherin displayed a sharp demarcation between the huno)' cells and thc 
normal urothelium (Fig. 1 B), 
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Figure I:Low power overviews (?i' human Madder carcinoma cells adjacent 10 primal)' 
normal mouse IIrolhelium: A) T24 cells alld B) RTl12 cells. Bladder carcinoma cells were 
selectively stained willi RCK10S. Scale bar = IOOplJl. (U=ul1slailled normal surrounding 
mouse urolheliuf}/.). 
The 6 tumor cell lines further differed with respect to their subsequent lEE rate (Fig. 2 and 
Table I). Thc lEE of bladdcr carcinoma cells was most pronounced for the SO cells and less 
for the 1207 and RTI12 cells, whereas T24, .ION, or .182 displayed hardly any or no 
expansion. Therefore. three of four E-cadherin-positive bladder carcinoma cell lines had a 
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bctter lEE rate tlwn the hvo E-cadherin-ncgative bladder carcinoma cell lines. These results 
suggested <I positive effect ofE-cadheI"in on lEE. 
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Figure 2: lEE 0/6 d{!ie}'ent hladder tumor eel/lilies. 
Graphs display the area (111m2) occupied by IUIfIUl1l hladder tumor cells in peripheral lesions 
measured 01/ d{Oerellt time points. Data are e.\]Jressed as means ± SD (1/=6 cultures, with 
four peripheral lesions e(/(:h). Note the d{Oerence in the scale of the y-axis in the varioIls 
graphs. 
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Table 1 Characteristics of lEE of bladder carcinoma cell lines 
lEE 
Cell line E~cadherin expression Tumor expansion Infiltration pattern (in vitro) 
SD + ++ Sharp demarcation 
T24 -/+ Single cells 
RTll2 + + Sharp demarcation 
J82 Single cells 
JON + -/+ Sharp demarcation 
1207 -/+ + Single cells 
Tral/~Iectiol1 qfT24 withfull~ienglh mouse E~cadheJ'ill eDNA 
To investigate ,,,hether E-cadherin is involved in the lEE of bladder tumors, we 
transfected T24 cells with the mouse E-eadhcrin gene. Earlier, it was shown that T24 cells 
express Q- and J3-catcnin (25). \Ve obtained nineteen G418-resistant T24 cell clones, with 
membrane-bound E-cadherin expression (Fig. 3A). 
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Figure 3: Ana(rsis (~r E-eadheJ'in expression in tran~re('led T24 clones. 
immunojilloJ'escellt stainingjor E-cadheJ'in in T24D10++ (AJ [magn(licationlOOX). 
lVes/em blol/illg oOo/a//ysa/es ~fMDCK, T24, alld T24 //"OII,!fedall/s (B), 
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Clones varied ,vilh regard to their levels of iml11unohistochemically detected E-cadherin 
expression. Expression levels of E-cadherin of nine different T24 transfectants were analyzed 
by flow eytomehy. Clones T24H9+, T24 2D4+, T24D4+ and T24H5+ had low to moderate 
expression levels (Fig. 4B), whereas the clones T24H3++ and T24DIO++ had a high 
expression level of E-cadherin (Fig. 4C). As a negative control for E-cadhcrin expression, we 
used the clones (T24CI-, T24FI-, and ,[2401-) that were 0418 resistant hut had no detectable 
expression of E-cadherin either by immunofluorescence, immunoblotting, or flow cytometty 
(Fig. 4A). lmmunoblotting with the DECMA-I 'antibody on different cell Iysates of '[24 
clones showed a characteristic band at 120 kD that was typical of the E-eadhcrin-positive 
clones (Fig 38). At the uitrastmctural level 110 difference in the presence of desll1osomes 
betwcen the nontransfected (E-eadherin-negative) and transfected, E-cadhcrin-positive T24 
cells was noted (data not shown). 
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Figure 4: Flow cytometl)l analysis of E-cadherin e.\pressioll ill A) native T24 cells and the 
lIegatil'e cOlltrols T24CI-, T24FI-, T24GI-; B) Clolles T24D4+, T24 2D4+, T24H5+, 
T24H9+ alld C) c/olles T24D10++ and T24H3++. 
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Wound colonizaNoll assay 
The capacity to repair lesions in a confluent cell culture was monitored for the 
different clones. Strikingly, lIntransfeeted T24 cells and the T24 clones T24Cl-, T24Fl- and 
T24G 1-, with no E-cadherin expression, migrated into the denuded arca as single cells (Fig. 
SA). SD and the T24 clones with a high or moderate E-cadhcrin expression tIlled up the 
lesions by moving <IS a cohesive sheet (Fig. 5B and Table 2). However, no difference in time 
required for the repair of the lesions was seen. 
Figure 5: Wound colonization of tran~fected 1'24 cells. The photographs illustrate the 
dUrerence ill wound·:/illing capacity between the E-cadherifl-negati\'e 1'24 clone, 1'24GI- (A) 
and an E-cadherin-positive clone, T24D1()++ (B). 
1n vitro emblyonic chicken heart invasion assay 
111 vitro invasion of bladder carcinoma cells "ms examined after 6 days of eocultivation 
with embryonic chicken heart fragments. As a negative control, we used the E-cadherin-
positive SD cell line. Tumor cell adhesion to chicken heart fragments varied from 100% for 
T24D 10++ and T24H3++ cells to 65% for the T24 cells (Table 2). Untransfeeted T24 cells 
exhibited the strongest invasive capacity. Aner successtlll <ldhesion, T24 hUl10r cells 
infiltrated nearly all emblyonie chicken heart fragments (87%). SD cells were unable to 
invade the embryonic chicken heart fragments at all. Transfection of E-cadherin in T24 cells 
resulted in a significant reduction of invasion for T24D 10++ and T24H3++ (Table 2). Both 
cell lines had a high expression ofE-cadheril~, Clones T24H9+, with a moderate expression of 
E-cadherin, T24C t - and T24G 1-, ''lith absent E-cadherin expression, exhibited a moderate to 
high invasive capacity into the embryonic chicken heart fragments. These results revealed the 
levels of E-cadherin expression of the transfected T24 clones corresponded with their 
functionality. 
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Table 2 III vitro invasion ofE-cadherin-transfected 1'24 cells 
E-eadherin In vitro confronting cultures \Voune! Cell linc expression of 
colonization 
cultured cells Adherent<l Invasivcb 
SD ++ 20123 (87%) 0120 (0%) Cohesive sheet 
T24 15/23 (65%) 13/15 (87%) Single cells 
T24DIO++ ++ 34/34 (100%) 3/34 (9%) Cohesive sheet 
T24H3++ ++ 11111 (100%) 2/11 (18%) Cohesive sheet 
T24H9+ + 21122 (95%) 7121 (33%) Cohesive sheet 
T24GI- 21121 (100%) 11121 (52%) Single cells 
T24CI- 20/21 (95%) 15/20 (75%) Single cells 
T24H5+ + 11/12 (92%) 3/11 (27%) Cohesive sheet 
a) Number of adherent I total number ofconironk'd embryonic chicken heart cultures; 
b) Number of invasive I number of confronted cultures with adherent tumor cells. 
lEE o!'tralls!'ected T24 cells 
The SD cell line was used as a positive control, because it had the highest expansion 
rate of the Tee ceUtines (Fig. 2). Transfection of 1'24 cells with mouse E-cadherin eDNA 
stimulated lEE of two independently obtained cloncs, 1'24DIO++ and T24H3++, both with a 
high expression of the E-cadherin protein (Fig. 6). 
Clones with a moderate/low expression level of E-cadherin (e.g., T24H9+) did not 
show a significant stimulation of lEE. The implantation (denned by the hunor area on day 1) 
of the different T24 transfectants was comparable, indicating that possible differences in lEE 
could not be attributed to differences in attachmcnt of the T24 transicctants to the wounded 
area. 
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The expression of integrins \vas detennined by How cytometry in T24, T24H3++, T24D 1 0++ 
and T24C t~. In the four tested clones, no differences were observed in expression levels of 
uJ~, o.2~, 0.3-, o.4~, o.5~, u.6~, P 1-, or JB-integrins (data not shown). 
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Figure 6: lEE (~rT24 trans/ectants. Graphs display the area (nun 2) occupied by human 
bladder tuwor cells in peripherallesiolls measured 011 dUferent time points. Data are 
e.\pressed as means (J1=4/5 cultures, withjvurperipherallesions each). 
E.\pansion (~f T24 clones on collagen type lV~coated c)'dopore membranes in the ahsence of 
surrounding urathelium 
Vole tested whether the observed differences in lEE rate between the tested T24 clones 
could be explained by an altered expansion rate (expansion defined as the outgrowth of a 
sheet of cells) or proliferative capacity. The expansion of different T24 clones in the absence 
of surrounding urothclium \vas assessed (Fig. 7). These experiments revealed no differences 
in the outgrowth or in the CH]thymidillc incorporation (data not shown) of the various T24 
clones. The moderately E-cadherin-expressing T24 2D4+ had a lower expansion rate. 
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Data are expressed as means (11=4 cultures). 
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DiscLlssion 
The lEE assay used here is considered an experimental model relevant for the study of the 
mechanisms underlying the in vivo expansion of carcinoma in situ of the bladder, because in 
this model, lEE is the outcome of the balance between the regenerative potential of normal 
urathelial cells and the growth of transformed ceils, Previolls studies have shown that this in 
vitro lEE may be influenced by exposure to growth factors and by culture on substrates 
composed of particular extracellular matrix proteins (10,11). These earlier studies suggested 
that modulation of lEE was largely the consequence of the interaction of these factors with 
the BOllnaI urothelium, rather than a direct effect 011 the bladder carcinoma cells, The 
observed considerable variation among the six tested TCC cell lines in their capacity to 
expand at the expense of normal urothelium implies that factors intrinsic to these cell lines 
also determine the outcome of the cocultivations, 
Previously, we have shown that the pattern of inf1ltration ofTCC cells into the surrounding 
normal urothelium is determined by E-cadherin expression (10,11). E-cadherin negative TCC 
cells inf1ltrate the normal urothelium as individual cells, whereas tUlllor cells with a 
homogeneous expression of E-cadherin exhibit a sharp demarcation with the normal 
urothelium. The 1207 TCC cell line with a heterogeneous expression of E-cadherin ill vitro 
also displays the capacity to infiltrate the normal urothelium as individual cells. Staining of 
these cocultivations with a human specific E-cadherin antibody revealed that the infiltrative 
single cells of the 1207 cell line had a reduced or absent expression of E-cadherin as 
compared with the high homogencous expression of the primaty tumor at the implantation 
site (data not shown). These results indicate that a reduced or absent expression of E-cadherin 
results in infiltration of the surrounding normal urotheliulll as single cells. 
Comparison of the six TCC cell lines revealed that the two constihltively E-cfldherin-
negative bladder carcinoma cell lines (T24 and J82) hardly showed any lEE, whereas three of 
lour E-cadherin-positive cell lines (SD, RT112, and 1207) did. We hypothesized that a 
functional E-cadherin-catenin complex is required for effective lEE of TCC cells. To fmiher 
test this hypothesis, we established stable transfectants of T24 cells expressing the ful1-length 
mouse E-cadherin eDNA. Several clones of E-cadherin-expressing 1'24 cells were obtained. 
Functionality of the transfected T24 clones was analyzed with the embryonic chicken heart ill 
vitro invasion assay (12,26) and a wound colonization assay (27). 
The E-cadhcrin-negative cell line T24 was generally capable of invasion into the 
embryonic chicken hcart, whereas only the T24 transfectants with high expression of E-
cadherin (T24H3++, T24DlO++) had a significantly reduced invasive capacity, implying a 
functional E-cadherin-catenin complex. The T24 clones with a moderate/low, but 
homogeneous expression of E-cadherin (e.g., T24H9+) retained part of their invasiveness 
(Table 2). This observation is in accordance with those of Vlemillckx et al. (12) \vho 
suggested that a threshold expression of E~cadherin has to be reached in order to prevent ill 
vitro invasion into the emblyonic chicken hemt fragments. Similarly, in lEE assays a 
significant enhanced expansion rate was only observed fbI' the two T24 clones with high E~ 
cadherin expression but not for the T24 clones with a moderate or 100v expression level, 
suggesting that the same E-cadhcrin mediated mechanism induces both suppression of ill vitro 
invasion and promotion of lEE. The enhanced E-cadherin-mediated expansion rate became 
manifest only under the cocultivations conditions of lEE. Thus, increased expression of E-
cadherin by trans fee ted T24 cells \vas neithcr associated with an increased expansion rate on 
collagen type IV-coated membranes nor with an increased proliferative activity or \v0l1l1d 
repair. Several reports documented E-eadhcrin-mediated suppression of cell motility and 
inhibition of proliferation (27-29). This discrepancy with our findings on T24 cells may bc 
explained by the usc of fibroblast cells in these studies rather than epithelial cells. 
Furthermore, the motility assays used in thcse reports (27-29) were based on single eell 
assays, whereas our expansion assay (Fig. 7) monitors the outgrowth of a cohesive sheet of 
cells. 
Recently, Pignatelli (30) spcculated on the possibility of a molecular cross-talk between 
cadherins and integrins in cancer cells. Because integrins are involved in motility and could 
be a regulator in lEE, we examined whether E-cadherin expression levels in transfected T24 
eells would correlate with expression levels of integrins. Flow cytometric analysis of o.l~, o.2~ 
,0.3-, (.(4-, a5-, ((6~, Pl-, or p3-integrin expression levels did 110t point to such a mechanism 
in E-eadherin transfected T24 cells. It could still be argued that E-cadherins eould lead to an 
altcred localization or affinity of integrins on the cellmcmbrane. Because we did not tlnd any 
altered migratory behavior of the transfected T24 cells in our expansion assay in the absence 
of surrounding normal urothelium, E-cadherin-integrin cross-talk in our transfected T24 eells 
seems an unlikely mechanism for the observed lEE. We strongly feel that cohesion of 
transformed T24 cells is the most important E-cadherilHnediated determinant for lEE. 
X9 
Our study suggests that E-cadherin is an imp0l1ant molecule for lEE ofTCC in vitro, but it 
does not prove that this vie\v holds true for bladder carcinoma il1 situ. Although a number of 
studies analyzed E-cadhcrin immunoreactivity during different stages of bladder cancer 
progression, none reported on the E-cadhcrin expression in carcinoma in situ of the bladder in 
detail (15-17,31). In a preliminmy study, we stained paraffin sections with carcinoma in situ 
of ten patients for E-cadherin. All of these ten lesions had a normal, homogeneous, 
membranous expression of E-cadherin, confirming our hypothesis on the contributory role of 
E-cadherin in the intraepitheliai propagation of bladder carcinomas. 
For carcinogenesis in \'i\,o, our observations would imply that on the one hand, E-cadherin 
promotes expansion of carcinoma in situ and on the other hand, opposes invasiveness of the 
transformed cells. Gencralizing, E-cadherin-mcdiated cohesivencss may represent a major 
property of transformed clones, allowing carcinoma ill sitll to expand at the expense of 
surrounding normal epithelial cells in vivo. 
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Chapter 5 
INFLUENCE OF THE MICROENVIRONMENT ON INVASIVENESS OF HUlIIAN 
BLADDER CARCINOMA CELL LINES 
Eric M.J. Bindels, Marcel Vermey, Nico J. De Both and Theodol1ls H. Van DcI' Kwast 
Department of Pathology, Erasmus University, Rotterdam, The Netherlands 
Abstract 
To investigate the impOliance of the microenvironment in bladder cancer invasion, a panel 
of 6 bladder carcinoma cell lines (SD, RTlI2, JON, 1207, T24, .IR2) was tested both in ill 
vitro and ill vivo invasion assays. Fm1hermore, invasiveness Was con"elated with the 
expression of components of the E-cadherin-catcnin complex. 
The E-cadherin negative cell lines, T24 and J82, displayed a high ill vitro invasive 
capacity, whereas the E-cadherin positive cell lines, SO and JON, completely lacked in vitro 
invasive capacity. in contrast, in vivo invasion was noted for aU cell lines, \"ilh the exception 
of cell line JON. Most notably, SD formed highly invasive tUlllors ill vivo, The in \'ivo 
invasiveness of the E-cadhcrin positive bladder carcinoma cell lines ,vas associated with a 
heterogeneous expression of the E-cadherin-catenin complex. The discrepancy between in 
vitro and in vivo invasive behavior implies that in vivo the microenvironment plays an 
impOliant role in the establishment of the invasive phenotype. In addition, it was found that 
orthotopic xenograft-ing of 1207, rcspectively T24 bladder carcinoma cclls resulted in sitc-
specific tumor take, respectively an enhanced tumor outgrO\vth and invasivencss as compared 
to heterotopic (i.e. subcutaneous) inoculation. 
\Ve conclude that the site-specific growth and invasion of the bladder carcinoma cclllines 
ill vivo and the observed assay specific invasion (ill vitro vs. ill \'1\'0) points to an effect of the 
local (bladder) microcnvironment on tUlllor cell behavior. 
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Introduction 
Bladder cancer is the fifth most common malignancy in males in the westem \vorId. From 
a clinical point of view, bladder cancers can bc divided in superficial and deeply invasive 
tumors. Superficial bladder carcinomas have a relative good prognosis, despite a high 
recurrence rate after transurethral resection (Kurth et aI, 1989). Only a small proportion of 
these superficial carcinomas progress to invasive disease, and distant metastases only seldom 
develop (Liponnen, 19X9). Invasive bladder carcinoma, however, has a mueh less favorable 
prognosis than superficial bladder carcinoma. Despite the use of aggressive therapies, 
invasive bladder carcinomas have a five-year survival ratc of 50% or less (Raghavan et ai, 
1990). The key regulators involved in the invasion of bladder tumors into the bladder wall arc 
ollly partially understood. A fill1her elucidation of these processes requires relevant ill vhf'O 
and ill vivo tumor models. 
A currently available ill \'iII'O model for hllnor invasion is the well-documented emblyonic 
chicken heart invasion assay. whieh has been used to study several epithelial huno!' systems 
(Vleminckx et ai, 1991; Behrens et aI, 1993; Vermeulen et ai, 1995). Since paracrine effects 
of the host tissue may regulate the expression of invasion promoting or suppressor moJ.ccuies, 
it can be anticipated that il1 vitro observations may not necessarily be identical to in vivo 
findings. Furthermore, for some tUlllor systems it was demonstrated that the site of tumor cell 
inoculation might influence tumor growth, invasion and metastasis (Morikowa et ai, 1988). 
Pat1icularly, orthotopic xenografting has been shown to enhanee tumor take, invasive 
properties and metastatic behavior of a number of human carcinoma cell lines (Naito et ai, 
1988; Rembrink et ai, 1997). Therefore, we compared the ill \'ilro invasive properties of six 
human bladder carcinoma cell lines with their invasiveness after orthotopic and heterotopic 
inoculation in SCJD (severe combined immunodeficiency syndrome) mice. SCID mice were 
chosen as a host strain, since it was demonstrated that these mice were more apt to permit 
xenograft take than nude mice (Chang, 1966; ealafet aI, 1993; .Iankun et ai, 1997). 
An initial step in the invasive process is the detachment of tumor cells from the in situ 
carcinoma. It has been proposed that loss of cell-cell adhesions is a prerequisite for 
detachment of cells from the primary tumor mass. Epithelial cell-cell adhesion is primarily 
determined by the E~cadherin-catenin complex. In tumor models, loss of E~cadherin 
expression appears to be associated \vith the gain of the invasive phenotype. Similarly, loss of 
the invasion suppressor molecule E-cadherin is predictive for poor survival of patients with 
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bladder cancer (Bringuier et ai, 1993; Syrigos et ai, 1995). Furthermore, abnormal expression 
of the cytopiasmatic, E~cadherin associated, proteins (a-,p~,y~ catenin and pI20CO-I) was also 
correlated with tumor grade, stage and poor prognosis (Shimazui ct ai, 1996). Because these 
studies suggest that the downregulation of the E-cadherin-catenin complex is involved in 
invasive bladder carcinoma, we also studied the expression of members of the E-cadherin-
catenin complex during the ill vitro and ;'1 vivo invasion assays. 
Our results showed that the used transitional cell carcinoma (TCe) celliincs had different 
cell biological behavior in the applied bioassays. In vitro, invasion of the Tec cell lines into 
the embryonic chicken heart fragments was strongly correlated with abscnt or heterogeneous 
expression of E~cadherin. However, transplantation of tumor cells into SCID mice resulted in 
an enhanced invasive capacity of thc E-cadhel"in positive Tce cell lines. Furthellllore, two 
Tee cell lines (1207 and T24) exhibited site specific growth and invasion. These results point 
to a specific influcnce of the (bladder) microcnvironment on tumor growth and invasion. 
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iVIatel'ial and l\'Iethods 
eel/lines 
The human bladder cancer cell lines '1'24, SD, RT 112, JON and J82 were kindly provided 
by Prof. Dr. J.A. Schalken, Urological Research Laboratory, University Hospital Nijmegen, 
The Netherlands, and have been characterized previously (Paulie et ai, 1983; Mastcrs at aI, 
19S6). Bladder carcinoma calliinc 1207 \vas obtained from Dr. \V.L De Boer, GETU Service 
d'Urologie, Paris, France (De Boer ct ai, 1997). Cells were maintained in DMEM 
supplemented with 10% heat-inactivated FCS, 1O0 IU/llll penicillin and 100 ~lg/ml 
streptomycin at 37°C in a 5% CO2 atmosphere. 
Alltibodi('s 
Monoclonal antibody RCK108 directed against cytokeratin 19 (Eurodiagnostica, Arnhem, 
The Netherlands) or monoclonal antibody oCtO directed against cytokeratin 18 (Beckman 
Coulter, Fullerton, CA, USA) were used to distinguish the human bladder carcinoma cells 
from murine tissue (in vim assay) or embryonic chicken heart tissue (ill vitro assay). This is 
based on the species specificity of these two antibodies for human cytokeratins. Monoclonal 
antibody DC I 0 was used for staining J82 cells whereas the other cell lines were stained with 
monoclonal antibody RCK108. Nearly 100% of the bladder carcinoma cells of each cell line 
were labeled with RCK108 or octO. The mouse monoclonal anti-bromodcoxyuridine (BrdU) 
antibody IIB5 (kindly donated by Dr. B. Schutte, University of Maastricht, The Netherlands) 
was used to visualize cells that had incorporated BrdU during the S-phase of the cell cycle. 
Expression of E-cadherin was demonstrated with the monoclonal antibody 5H9 
(Eurodiagnostica), raised against an 80-kDa hyptic fragment of E-cadherin derived from 
human A-431 carcinoma cells. This antibody also detects the 120-kDa mature E-cadherin 
protein (Moll et ai, 1993). The monoclonal antibodies against 0.- and p-catenin were obtained 
from Transduction Laboratories (Lexington, USA). 
Imm/(}whi,\"tochemisflJ' 
E-cadherin, 0.- and p-catenin expression by bladder tumor cells ill vitro was determined as 
follows. Cell lines \vere cultured on multi chamber slidcs until contluency was reached and 
fixed in cold acetone (_20°C) for 1 hour. After dlying, thc slidcs wcrc incubated with the 
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different prinuuy antibodies followed by visualization with FITC-conjugated rabbit anti-
mouse immunoglobulins (Dako, Glostmp, Denmark). 
For immul1ohistoehemishy on paraffIn embedded tissues, five I 1m thick paraffin sections 
were mounted on 3-amino-propyl-tri-ethoxy-silane (Sigma, St. Louis, USA) coated slides and 
dried overnight at 37°C. Sections were deparafflnizcd, endogenous peroxidase was blocked in 
3% H20 2 in methanol (20 minutes) and rinsed in PBS. 
For antigen retrieval, sections werc digested for 10 minutes in 0.1 % pronase (Sigma) 
(containing t% eaCh for E-cadherin staining) in PBS. Prior to a- and p-catcnin staining, 
sections were boiled twice for 5 minutes in a solution of 0.0 I M citrate (pH 6.0) in a 
microwave oven. Paraffin sections ofnonnal human skin \vere used as positive controls for E-
eadherin, 0.- and p-catenin staining. For BrdU-staining, after the antigen retrieval proccdure 
was performed, slides were incubated in 2N HCI for 30 minutes, followed by a two times 5 
minutcs wash with Borax buffer (Schutte ct ai, 1987). Prior to the application of the primary 
antibodies non-specific binding was blocked with 10% normal goat serum diluted in PBS 
containing 1 % bovine serum albumin. Incubation with the primal}' antibody was followed by 
a biotinylated goat anti-mouse antibody (Dako) and subsequently a horseradish peroxidase 
conjugated streptavidin-biotin complex (Biogenex, San Ramon, USA), Peroxidasc activity 
was visualized with 0.03% H20 2 and 0.02% 3,3,~diaminobenzidine tetrahydrochloride (DAB; 
Fluka, Basel, Switzerland) diluted in PBS. The slides were cOllntcrstained with Mayer's 
hematoxylin, dehydrated and mounted. 
111 vivv tumorigenicity a/eel/lines 
The tumorigenicity of each cell line was tested in six weeks old fel11<1le SCID mice (B171 
lCR Han Hsd-SClD), obtained from Harlan (Zeist, The Netherlands). Bladder carcinoma cells 
suspended in Hanks buffered salt solution were injected both subcutaneously (± 4 x 106 cells) 
in a volume of 200 ~!1 and in the submucosa of the bladder (± 106 cells) in <I volume of 50 ~li. 
For inoculation of tumor cells in the bladder wall an abdominal incision was made in mice 
anaesthetized with avertine (0.25 mg/g body weight). One hour before the mice were 
saerif1ccd, they received an intraperitoneal injection of BrdU (40 mg/kg body weight) in 0.15 
M NaC!. Under a dissecting microscope tumor inoculation sites plus other relevant organs 
were removed and tlxed in 4% phosphate-buffered formalin for t 6 hours before paraffIn 
embedding. 
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Determination of the proli(erative activity of Tee in vivo 
Proliferative activity was determined by counting BrdU-positive nuclei in a total of 1000 
nuclei, at four random areas of the hunor. Proliferation is expressed as the labeling index: 
Number ofBrdU-positive nuclei! total number ofnucJei x 100%. 
l\1mpliometlJ' 
The size of in \,ivo formed tumors was estimated by image analysis. Serial sections were 
cut and the estimated largest tumor area was determined fi"Olu the immunostainings with the 
RCK108 or DC 10 antibody, Subsequently, these hunor areas were quantitated with a Hitachi 
CCTV camera equipped v'lith the KS400 image analysis software package (Kontron 
Elektronik, Eehing, Gennany), 
In vitro invasion assay 
Chicken heart invasion assays were performed as described by Mareel et al. (1977). 
Briefly, human bladder tumor cells were confronted with precultured rounded fragments of 
emblyonic chicken hemt on soil agar for 24 hours. Next, the fragments with attached bladder 
tumor cells were kept in suspension culture under gyrotory shaking (120 rpm, 37°C) in MEM 
REGA 3 medium (GibcoBRLlLitc Technologies, Breda, The Netherlands) containing 10% 
FCS. Aner 6 days of cocultivation, fragments were tixed in Bouin-Hollanders solution and 
embedded in paraffin. Invasion was scored 011 serial histological sections stained with 
hematoxylin/eosin. The hunor cells can be discerned tl'OlU the heart tissue by their more 
basophilic staining. Additional confirmation of invasion was obtained by selective keratin 
(RCK I 08, DCIO) immunostaining of the human bladder carcinoma ceUs. 
J\I01phology o/tumor cells 0111\latrigel 
The morphological appearance of bladder hunor cells on Matrigc1 was assessed. Therefore, 
200 pi growth factor reduced Matrigel (9.64 mg/ml; Becton Dickinson, Bedford, USA) per 
well was allowed to polymerize for 30 minutes at 3JOC in a 24-wells plate. Subsequently, a 
same lvlatrigel solution containing I x 104 tumor cells \vas poured on top of the polymerized 
matrigel. After the gelation of the second Matrigel solution, standard culhlrc medium \vas 
pipetted on top of it. After 1 week, 1TI00]Jhology of the bladder hunor cells (epithelial or 
fibroblast-like) was recorded by microscopical examination. 
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Results 
In vh'o tumorigenicity 
Tumor take, tumor size, muscle invasion and proliferative activity after heterotopic 
(subcutaneous) and orthotopic inoculation of each of the six cell lines wa~ examined (Table 
I), A tumor take of lOO% \vas observed for SD and RTI12 bladder carcinoma cells both after 
0l1hotopic and heterotopic inoculation. Both cell lines clearly invaded the muscle tissue 
underlying the skin or bladder mucosa (Figure lA, I B), The size of the subcutaneous tumors 
was 4~ to lO-fold larger as compared to the bladder tUl11ors, possibly reflecting the larger 
number of cells inoculated subcutaneously. SD and RTl12 tumors occasionally penetrated 
through the bladder muco~a into the bladder lumen. The normal mouse urothelium covering 
the tumor had often a hypeIJ)lastic appcarance, ,vhich may be attributed to the paracrine 
action ofhlll1or-dcrived growth factors (De Boer ct ai, 1994). 
D 
Figure 1: TUlllorigenicity of bladder tU1110r cells. Tumor cells were selecth'ely stained with 
RCK lOS. Invasion of RTI 12 cells into tlte submucosa and muscularis (~(the bladdel' (A) and 
the skeletal muscle lflldemeatlt tlte skill (B). Note tlte clump q{ RTI I 2 cells ill a peri vesicular 
~l'lIIph vessel a/tlte hladder (Fig. IA,' (/}TaH~. Part (~ra large orthotopic (umor (d'T24 cells ill 
lite bladder (C), and as a reference tlte small tUlIlor in tlte subcutis (D). Scale bar = 100pm. 
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Table I: HETEROTOPIC AND ORTHOTOPIC TUMORIGENICITY OF BLADDER CARCINOMA CELL LINES 
Cell line Mean Bladder Subcutaneous E- Labeling Indexb Estimated largest area 
follow-up cadherin 
period in tumor take muscle tumor take muscle in vivoU. bladder subcutaneous bladder subcutaneous 
days invasion invasion mean±Stdev mean±stdev mean±Stdev mean±Stdev 
(range) 
SD 39.5 4/4 4/4 4/4 4/4 Htr. 13.4±9.3 16.3±3.4 6.0±6.5 21.2±1O.8' (35-53) 
RT1l2 37.5 4/4 3/4 4/4 3/4 Htr. 22.0±1.6 19.4 35±4.1 34.6±19.3· (27-53) 
T24 58 4/4 3/4 3/4 0/3 Neg. 10.3±2§ 2.0±0.7 4.0±1.l· 1.2±1.6 (35-74) 
1207 50.6 4/5 2/4 0/5 010 Htr. 16.1±3.8 2.2±2.6 (29-53) 
Jon 50.2 5/5 0/5 4/5 0/4 Hom. 16.3±2.6 13.2±4.3 1.5±1.5 2.6±1.6 (31-57) 
J82 42 2/5 0/2 115 111 Neg. 21.0±0.0 17.3' 3.1±4.1 53.2 (40-53) 
:1) Htr.: hctcrogcncoU$. Hom.: homogeneous. Neg.: absent expression at the cell membrane: b)labcling index: pcrccnt:l.gc ofBrdU positive cells: 
c) no subcutaneous tumors: * = significantly different in bbdocr as compared to subcutaneous CHest: P<O.05). 
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\Ve observed a high take rate atter both heterotopic and orthotopic inoculation ofT24 
cells in SCID mice (Table J). Strikingly, subcutaneous T24 tumors were rather small and no 
muscle invasion was noted (Table I, Figure I D). In contrast, T24 tumors, localized in the 
bladder, were about 3-fold larger, shO\ved muscle invasion (Figure Ie) and had a signif1cantly 
higher proliferative activity as compared to subcutaneous T24 tumors (Table I). 
Site specific tumor take was seen for cell line 1207. Although in 4 out of 5 mice, 
orthotopic ally injected ''lith 1207 cells, tumors had developed in the bladder wall (2 were 
muscle invasive), no tumors were found at the subcutaneous injection sites despite of the 
larger number of subcutaneously inoculated tumor cells. Microscopic examination of the 
subcutaneous injection sites con finned this observation. The two muscle invasive 1207 
tumors also showed penetration into the bladder lumen. 
JON cells demonstrated a high take rate both hetero- and orthotopicaily, but muscle 
invasion was completely lacking. The subcutaneous JON tumors showed an expanding 
growth pattern with shmV tumor borders. These tumors \vere associated with an inflammatory 
infiltrate. The tumor take of J82 was low, both after olihotopic and heterotopic inoculation. Tn 
one mouse a large muscle invasive subcutaneous tumor was found. 
In none of the injected mice lymphogenic or distant metastases were found, but regional 
lymph vessels in the loose connective tissue surrounding the bladders of mice injected with 
SD, RTl12 or T24 bladder carcinoma cells occasionally contained isolated small tumor 
aggregates (FiglA). 
In vitro embJ},oJ1ic chicken heart invasion assay and tUllIor cell JJl0I1J/1O/ogy oJ11\latrigel 
III vitro invasion of bladder carcinoma cells was examined after 4-6 days of cocultivation 
\vith emblyonic chicken heali fragments. Adhesion of hlluor cells to chicken hcal"t fragments 
varied from 53% of the cases for JON and J82 cells to 97% of the cases for the SD cells 
(Table II). 1'24 and J82 cells showed the strongest invasive capacity. Aner successful 
adhesion nearly all emblyonic chicken heart fragments were illt1ltrated by these E~cadherin 
negative tumor cells (Figure 2A). RT112 and 1207 (Figure 213) cells had a moderate capacity 
(33% and 39% of the cases, respectively) to invade hemi thlgments, whereas SD (Figure 2C) 
and JON (Figure 2D) cells were not able to invade the emblyonic chicken heart fragments at 
all. The SD cell line formed a clear epithelioid cell layer around the embryonic heart tissue, a 
feature characteristic for cells with a functionally intact E~cadherin-catenin complex 
(Vermeulen et ai, 1995). 
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To determine the epithelial or mesenchymal ITI0I11hotype of the used eell lines, cell lines 
were cultured in solid Matrigel substrate (method adapted from Venneulen et al., 1995), After 
one week of culture in solid Matrigel (Table II) the constitutively E-cadherin negative T24 
and J82 (Fig 2E) cells had a libroblastic morphology. In contrast, the E-cadherin posit ive cell 
lines SD (Fig 2F), RTl12 and JON expressed an epithelial morphology with formation of 
densely packed colonies. Bladder carcinoma cell line 1207 with a heterogeneous expression 
ofE-cadherin, had an epithelial morphology when cultured in Matrigel. 
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Figure 2: COI!/J'OJlting clIllures afinvasive and nOJlillvasl\'e Tce cells with em/)}),onic chicken 
heart. Photographs of parqtlln sections 0/ embl),onic chick hearl.kagmenls C01!/}'OI1Ied in 
organ clIlIlIre with T24 (A), 1207 (B), SD (e) or JON (D) cells. Bladder IlIlIIor cells were 
se/ecti\'ely slained with RCKI08. Scale bar = 1 ()Opm, except Figure 2D scale bar = 50pm. 
Phase contrast pictures o/JS2 (E) and SD (F) cells clfltured ill solid J\1atrigel. 
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TABLE II: IN VITRO INVASION OF TCC CELL LINES 
Cell line E-cadherin1 a-catenin f3-catenin In vitro In vitro Morphology 
expression expression expression confronting confronting Matrigel5 
in vitro in vitro in vitro cultures cultures 
Adherent' Invasive" 
SD Hom. Hom. Hom. 37/38 0137 TC (97%) (0%) Epithelial 
RTU2 Hom. Hom. Hom. 9/15 3/9 TC (60%) (33%) Epithelial 
Htr. 
18/30 16118 T24 Neg. Cytopl.lcell- Hom. (60%) (89%) Fibroblastic 
membr.2 
1207 Htr. Hom. Hom. 28/45 1l/28 TC (62%) (39%) epithelial 
JON Hom. Hom. Hom. 8/15 0/8 TC (53%) (0%) Epithelial 
Htr. 9117 8/9 J82 Neg. Cytopl.lcell- Hom. (53%) (89%) Fibroblastic 
membr. 
1) Abbreviations .:lS in table I. 
2) cytopl./Ccll~mcmbr. = cytoplasm/cell membrane. 
3) Number of adherent! total number of confronted embryonic chicken hc:ut cultures. 
4) Number of invasive ! number of confronted cultures with adhen:nt tumor cells. 
5) I=inv;l$ivc, TC4ight colonies (criteria adapted fTom Vcnnculcnet a!.). 
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In vitro and in vivo e.\jJression ofE-cadherin and u,- and B-catenin 
Data on expression of E-cadherin and u,- and p-catenin on confluent cultures of bladder 
carcinoma cell lines visualized by immunohistochemistry are summarized in Table II. 
Expression patterns of E-cadherin were compared between the in vivo and in vitro assays. 
Cell lines T24 and J82 lacked E-cadherin expression ill vivo ancl ill vitro (Table I & II). The 
cell lines SO and RT112 which display a homogeneous E-cadherin expression in vitro 
displayed a heterogeneous cell membrane immunostaining in vivo both in the subcutaneous 
tumors and in the tumors located in the bladder wall. Regions with normal expression of E-
cadherin were seen in the central areas of these tumors (Fig, 3A). Reduced expression of E-
eadherin was primarily seen in the invasive borders of these tumors (Fig 38), Strikingly, the 
isolated small aggregates of SD and RTll2 hunor cells in lymph vessels had a normal 
expression of E-cadherin (Figure 3C). The expression patterns of either u,- or p-catenin was 
similar to the expression pattem ofE-cadherill in the different hunors, 
c 
Figure 3: £.\pression (~rE-cadherin ill vivo. Normal e.\jJressioll ofE-cadherill ill a SD tumor 
(AJ. Reduced expression 0/ E-cadJrel'in in an invasive region of a subcutaneolls SD tumor (B), 
RTl12 cells in a perivesctllar lymph vessel of the bladder, with normal expression of E-
cadlzerin (C). Scale bar = 25pm. 
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DisclIssion 
The six human bladder carcinoma cell lines studied in this paper display a considerable 
heterogeneity of cell biological characteristics with respect to their invasive potential both in 
vitro and ill vivo. 
SCID mice proved to be a velY suitable host strain allowing successful grafling of all six 
examined human bladder carcinoma cell lines. This was emphasized by xenografting T24 
cells in SCID mice. Tumor take of T24 cells in nude mice is poor or absent both after 
orthotopic and heterotopic inoculation (Masters et ai, 1986; own observations). Strikingly, 
T24 tumor growth, as reflected by tumor size and proliferative activity as well as tumor 
invasiveness, was enhanced by the orthotopic inoculation (Table I). 1207 cells exhibited site-
specific outgrowth, since 1207 tumor take only OCCUlTed after orthotopic transplantation. No 
signs of distant metastases for any of the xenografted TCe cell lines were found. Although 
isolated (RT1l2, SO, T24) hllnor aggregates were found in the perivesicular loose connective 
tissue, no lymph node mctastases were found. The short follow-up period of 2 months may 
account for this. 
\Ve compared the ill vivo invasiveness of the various Tec cell lines with the results of the 
in \'itro assay. The results of the in vitro embryonic chicken heart invasion assay did not 
match the ill \'i\'O invasive behavior of some of the tested TCC cell lines, most notably so. 
The so cell line was not invasive ill vitro, but both after subcutaneous injection and after 
inoculation in the bladder wall SO cells developed muscle invasive hunors. Similar 
discrepancies between the emblyonic chicken heart invasion assay and in vivo invasiveness 
were reported earlier in a study on colorectal carcinoma cell lines (De Vries et ai, 1995; De 
Both et ai, 1999). Our results SUppOlt the view that the microenvironment may regulate 
invasive behavior of bladder carcinoma cells ill Vh'D, for instance by influencing the 
expression ofE-cadherin as suggested by Mareel el a/. (1991), or by induction of synthesis of 
extracellular matrix degrading proteins. 
Vie studied the immunochemical expression of the E-cadherin-catenin complex ill vivo and 
ill I'ilro and its correlation with invasiveness. The obscrved ill vitra expression of the various 
members of the E-eadherin-catcnill complex in the Tee cell lines \vas confirmed by western 
blotting by Giroldi e{ a/. (1999). ill vivo, a heterogeneous E-cadherin and catenin expression 
by so and RTl12 cells \vas observed, in contrast to their homogeneous E-cadhcrin--catenin 
expression in )'itra. Loss or reduced expression of the E-eadherin-catenin complex was 
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primarily seen in the invasive regions of these tumors. These findings as well as the normal E-
cadherin and 0.- and p-catenin expression by small aggregates of SO and RTl12 tumor cells 
in lymph vessels (early sign of metastasis) suggests that the microenvironment may 
transiently reduce the expression of the E-cadherin-catenin complex during formation of 
invasive bladder tumors in SCID mice. Transient downregulation of E-cadherin expression ill 
I'ifro is described previously and could possibly be accomplished through activation of 
exogenous c-jhs (Reichmann et al., 1992), via c-erbB2 (D'Souza and TayJOJ·-Papadimitriou, 
1994) or TGFp (Mietinnen el al., 1994). Furthermore, expression could be regulated by 
methylation of the E-cadherin gene or via tissue-specific responsive elements in the E-
cadherin promoter (Christofori and Semb, 1999). Recent investigations have identified the 
transcription factor Snail, which could bind to E-boxes in the human E-cadherin promoter and 
thereby represses transcription of E-cadherin (Battle eI al., 2000; Cano et al., 2000). 
Furthermore, Keirsebilek et al. described that the ;'1 vivo transient dO\vnregulation of E-
eadheril1 could be caused by instability of the E-cadherin mRNA (Keirsebilck ct ai, 1998). 
Recently, Bringuier el al. showed that abnormal E-cadhcrin immunoreactivity in bladder 
tumors is associated with mRNA-dO\vnregulation or post-transcriptional downregulation of E-
cadherin. In the same series of bladder tumors, no stl1lctural alterations of the E-cadherin gene 
were detected (Bringuier el al., 1999), These findings corroborate with our observations on 
the transient reduction of E-cadherin expression in invasive bladder tumors. 
A strong correlation was found bct\veen the in vilro expression of E-cadherin of bladder 
carcinoma cells and their ability to invade embryonic chicken heart fragments. Similar results 
were reported for cell lines of other origin (Vleminckx et ai, 1991; Behrens et aI, 1993; 
Vermeulen et ai, 1995). The two E-cadherin negative cell lines T24 and J82 were generally 
capable of invasion of the embIyonic chicken heaIt, whereas the (in vitro) homogeneously E-
cadherin positive SO and JON cells showed no invasioll. The epithelial morphology of these 
E-cadherin positive cell lines grown on Matrigel is in accordance with their functionally intact 
membrane bound E-cadherin-catenin complex (Vermeulen et ai, 1995). On the other hand, the 
in vilro invasive cell lines, T24 and J82, had a fibroblastic morphotype when cultured on solid 
Matrigel. This is in accordance \vith the observation that epithelial-to-mesenchymal transition 
is correlated with gain of motility and invasive disease (Hay, 1995). The 1207 cells \vith a 
heterogeneous expression of E-cadherin had a rather limited infiltrative capacity in the 
embIyonic chicken heart invasion assay. Surprisingly, RT 112 cells with in vitro homogeneolls 
E-cadherin and catenin exprcssion \vere also capable of cmbIyonic chicken heart invasion in 
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one third of the samples. Booth et a/. showed that RTl12 cells could invade the subepithelial 
capillary bed after culture 011 urinary tract stroma. In the same paper they shO\ved that these 
RTI12 cells had partially lost their E-cadherin expression (1997). A similar in vitro 
mechanism could have occurred in our embryonic chicken heari invasion assay. 
Tn conclusion, we have studied the invasive propeliies of six bladder carcinoma cell lines, 
with the lise of in vitro and ill vit'v invasion assays. We have shown that the use of SCID mice 
allows a high tumor take for bladder cancer cell lines, including those which proved to be 
poorly if at all tumorigenic in nude mice. On the basis of their site dependent tumor take, 
respectively tumor outgrowth, bladder tUlllor cell lines 1207 and T24 may be considered to 
resemble more closely organ confined human bladder carcinomas with regard to their 
response to growth modulating factors and extracellular matrix proteins. The view that the 
microenvironment influences the induction of bladder tumor invasion is suppOl'ted by the 
observation that the results of the ill vitro invasion assay of E-eadherin positive bladder 
carcinoma cell lines did not correlate well with their invasive proper1ies ill vivo. Transient 
downregulation of the E-cadherin-catenill complex may in part explain the observed invasive 
capacity in vivo of the latter cell lines. 
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Chapter 6 
A NEW IN VIVO MODEL OF CARCINOMA IN SITU OF THE URINARY IlLADDER 
Eric MJ. Bindels, Marcel VCI111ey, \Vinand N.M. Dinjens and Theodorus H. Van DcrKwast 
Depalimcnt of Pathology. Erasmus University Medical Center, Rotterdam, The Netherlands 

Abstl'Oct 
Carcinoma in situ (CIS) of the urinary bladder is a neoplasm with an uncertain clinical 
behavior. It is either detected as an isolated disease or it is found in association with papillmy 
or invasive transitional cell carcinoma (Tee). Results from mapping studies, foUO\v-up 
studies and genetic analyses gave evidence that CIS can be regarded as a precursor lesion for 
invasive bladder carcinoma. Relevant in vitro and in vivo models are needed to identity 
factors that are involved in the growth and progression of CIS. To establish an in vivo model 
of CIS, cells of various Tee cell lines were intraiuminally injected immediately after partial 
denudation of mouse bladders. All cell lines carried a p53 mutation associated with 
immunohistochemical overexpression of p53. The denuded bladders arc rapidly 
reepithelializcd \vith mouse urothclial cells and the injected tumor cells. By this procedure 
CIS lesions were observed with all used TCC cell lines. Cell line 1207 showed the highest 
frequency of CIS formation (70%) in the bladder. Next, the growth of the 1207-derived CIS 
was studied during six months. In this experiment 97% of the mice developed CIS-lesions. 
During the six months period we noted a steadily increase in the growth of the 1207-derived 
CIS, as was confirmed by high proliferation <lnd low apoptosis of thc tumor cells at all time-
points. Furthermore, we could demonstmtc that 1207-derived CIS shows signs of 
intraepithelial pagetoid spread of small clusters or single tUInor cells. Only in h.vo mice, 
besides formation of CIS, (limited) invasion was noted. This demonstrates that progression to 
invasive disease during the 6 months follow-up period is uncommon in this model. 
Importantly, this model provides evidence that an otherwise invasive hunor cell line loses its 
invasive potential as a consequence of implantation on the basement membrane. 
The established in vivo model of 1207-derived CIS in denuded mouse bladder is useful in the 
study of the growth of CIS. The described model can be used to design future intravesical 
chemo-, im1l1uno- or gene-therapies for CIS of the bladder. 
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Introduction 
UrinalY bladder cancer is the Hilh most common malignancy in males in \Vestcrn 
societies. At initial diagnosis, the majority (70-80%) of these bladder tumors concems 
superficial, non-invasive transitional cell carcinomas (TCC). AileI' treatment by transurethral 
resection, the patients presenting with superficial bladder cancer have a high risk of tumor 
recurrence (± 70%), which can ultimately lead to invasive diseasel. Only approximately 20-
30% of the TCC emerges as deeply invasive tumors that penetrate the basement membrane 
and show invasion into the underlying tissue of the bladder wall. Despite radical therapics, 
like cystectomy, the clinical outcome of these invasive tumors is poor2. 
Many papers repOli that high-grade TCC arc associated with the occun'encc of 
carcinoma in situ (CIS). CIS is characterized by the intraepithclial presence of dysplastic 
celis, without penetration of the underlying basement membrane. The occurrence of CIS in 
the flat urothelium adjacent to tumors is correlated with a higher probability of tumor 
rccurrences and/or invasion]"", The clinical course of CIS without accompanying invasive 
carcinoma is highly variable, but without treatment more than 50% progrcsses to invasive 
tumorsS, On the other hand, a significant minority of patients with isolated CIS will never 
have progression to invasive discase6,7. Although this variation in biological behavior of CIS 
clearly exists, CIS is generally regarded as the precursor lesion for invasive carcinoma, First 
evidence for a preexisting CIS phase before the onset of invasive carcinoma came from 
mapping studies of cystectomy specimenso>g and from follow-up studics lO• Furthermore, 
mutation and loss of heterozygosity (LOH) analyses have shown that CIS displays the same 
genetic alterations as invasive bladder hlmors ll ,12. The above results suggest that CIS is 
indeed the precursor lesion for invasive bladder carcinomas, but additional factors determine 
if progression occurs. To date, several factors are knmvn to be associated with the progression 
of CIS to invasive disease. These include diftllse growth, prostatic involvement, 
overexpression of p53 or proliferation-, surface- or hlluor-associated markers and loss of 
normal urothelial antigells i3 . 
Although CIS is regarded as a precursor for invasive bladder carcinoma relevant in 
vivo and in vitro models of CIS are rarc. Previously, we have established an in vitro model for 
the study of the intraepitheliai expansion of bladder tumor cells l4. \Ve showed that some 
human TCC cell lines were able to expand by replacing the normal urothelium. To develop an 
in vivo model of CIS, we inoculated tumor cells 011 partially denuded mouse bladders. The 
lIS 
mouse bladders were denuded to obtain a higher take rate and subsequent growth of 
inoculated bladder tumor cells. The denuded bladders are rapidly repopulated with mouse 
urolhelial cells and the injected human tumor cells. Earlier, Solmvay and Masters have shown 
that cauterization of the bladder wall prior to inscliion of tumor cells resulted in an enhanced 
take rate l5 • In our study, the intraluminal injection of the TCC cell lines in denuded mouse 
bladders resulted in some cases in the developmcnt of lesions within the bladder which have 
the characteristics of CIS. Because TCC cell line 1207 gave the best results with respect to 
tormation of CIS, ,ve further detenllined the growth kinetics of the intraepithelial tumors of 
this 1207 cell line. 
Our in vivo model rcpresents a useful tool for the study of the mechanisms that 
underlie the growth and progression of CIS. Future therapics that prevent the expansion and 
progression of CIS to invasive tumors can also be investigated in the described model. 
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l\'latcrial and Methods 
Cell lilies 
The human bladder cancer cell lines T24, SO, RTI12 wcre kindly provided by Prof. Dr. 
J.A. Sehalken, Urological Research LaboratOly, University Hospital Nij1l1egen, The 
Netherlands. Human bladder carcinoma cell line 1207 was obtained from Dr. W.1. De Boer, 
GETU Service d'Urologie, Paris, France16• Cells were maintained in Dulbceco's modified 
Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf Sel11111 (FCS), 
100 IU/ml penicillin and 100 ~lg/1l11 streptomycin at 37°C in humidified atmosphere with 5% 
C02. 
Del/llda/ion o..(bladder lll'Othelill11/ and suhsequen! inoculation albladder carcinoma cells 
Six weeks old female SCID mice (B 17/TCR Han Hsd-SCID; Harlan, Zeist, The 
Netherlands) were anaesthetized with avertinc (250 mg/kg body weight). The bladder was 
distended by intravesical injection of200 ~tI PBS via a catheter (0.28111111 inner and 0.61 mm 
outer diameter }lolythene tube; Portex, Hythe, United Kingdom). This overstretching \vas 
maintained for 5 minutes. The presence of blood in the urine was regarded as an indication of 
damage to the urinmy bladder. Immediately after damage, a suspension of bladder tumor cells 
(2 x 106 cells in 100 ~tl Hanks buffered salt solution (HBSS]) was injeetcd into the lumen of 
the bladder via the catheter. Voiding of urine was preventcd for 10 minutes by clamping off 
the external urinaty tract of the mouse. Mice were sacrificed between one and two months 
after the procedure. Thirty minutes before the mice were sacrificed, they received an 
intraperitoneal injcetion of 5~bromo-2'~deoxyuridine (BrdU) (40 lllg/kg body weight) in PBS. 
In the first experiment, comparing four different Tce cell lines, a total body autopsy was 
performcd and organs were fixed in 4% phosphate buffered formalin for 16 hours before 
embedding in paraffin. On basis of the results of the first experiment, the second experiment 
was performed under milder conditions of overstretching follov;red by inoculation of 1207 
cells only. Mice werc sacritlced at various time points aftcr inoculation of the 1207 tumor 
cells. In these experiments, the whole urinary tract including the regional lymph nodes was 
isolatcd. 
The inoculated human bladder tUlllor cells ''lere identified with a human specific 
eytokeratin 19 antibody, which lacks crossreactivity with mouse tissue, In this study, a tumor 
was scored <IS CIS when the tumor cells \'lere confined to the urothelium, ,vithout visual 
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penetration of the basement membrane. 
In an additional experiment, PBS with the addition of Indian ink \Vas used to distend the 
bladder, while omitting the subsequent inoculation of TCC cells. The Indian ink selectively 
attached to areas with total denudation of the urothelium. In this manner, the extent of 
denudation of the bladder urothelium could be visualized, 
Antibodies 
The following antibodies \vere used: mouse monoclonal antibody RCKI 08 directed against 
human eytokeratin 19 (Eurodiagnostica, Arnhem, NL); mouse monoclonal antibody to 
bromodeoxyuridinc (BrdU), clone lIB5 (kindly donated by Dr. B. Schutte, University of 
Maastricht, NL), mouse monoclonal antibody to p53 (DO-7; DAKO, Glostmll. Denmark) and 
rabbit polyclollal antibody to collagen type IV (Eurodiagllostica). 
ImlJ//lllOliislocliemistl)' 
For imlTIul1ohistoehemistly on paraffin embedded tissues, four ~lln thick paraftln sections 
were mounted on 3-amino-propyl-tri-ethoxy-silane (Sigma, Sf. Louis, USA) coated slides and 
dried overnight at 37°C, Sections were deparaffinized, endogenous peroxidase was blocked in 
0.3% H201 in mcthanol (20 minutes) and rinsed in PBS. For antigen retrieval, sections werc 
digested for JO minutes in 0,1% pronase (Sigma) in PBS, After the antigen retrieval 
procedure, BrdU-staining was performed by incubating the slides in 2N HC] for 30 minutes at 
37°C, followed by a two times five minutes incubation with Borax buffer (pH 8.5) and three 
times five minutes wash in PBS 17. In the case of collagen type IV staining antigen retrieval 
consisted of incubation in 0,4% pepsin (Sigma) in PBS for two hours at room temperature. 
Prior to the application of the primary antibodies non-specific binding was blocked with 5% 
non-fat dry milk diluted in PBS containing 5% bovine senllll albumin. Overnight incubation 
at 4°C with the primaty antibody was followed by a biotinylated goat anti-mouse antibody 
(DAKO) and subsequently a horseradish peroxidase-conjugated streptavidin-biotin complex 
or an alkaline phosphatase-conjugated streptavidin-biotin complex (Biogcncx, San Ramon, 
USA), As chromogen \ve used 3,3,-diaminobenzidine tetrahydrochloride (DAB) (Fluka, 
Basel, Switzerland), or New Fuchsin (Sigma). The slides were counterstained with Mayer's 
hematoxylin, dehydrated and mounted. 
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Analysis (~fj)rol~leration and apoptosis 
Sections were double stained with the BrdUIRCKI08 antibodies. The double staining 
procedure consisted of two sequentially performed streptavidin-biotin complex methods as 
described in the inullul1ohistochemistty section. The streptavidin-biotin complex reactive with 
the BrdU antibody was horseradish-peroxidase labeled, whereas the second complex reactive 
with the RCKI08 antibody was alkaline-phosphatase labeled. Proliferative activity of CIS 
(RCK108 positive cells) was determined by counting BrdU positive nuclei in at least 100 
tumor celJs. Proliferation is expressed as the labeling index: Number of BrdU positive nuclei! 
total number of nuclei x 100%. By morphological criteria we determined the number of 
apoptotic nuclei and expressed them as percentage of the total number of nuclei present in the 
CIS lesions (Apoptotic Index). 
Extent of CIS in mice inoculated with cell line 1207 
\Ve semi-quantitatively determined the extent of CIS in mice inoculated with the TCC cell 
line 1207. To this end, the bladders of these mice were sectioned completely. With 20-section 
intervals (80~lm), presence of 1207 cells was examined by cytokeratin 19 staining. 
Approximately 15 to 20 levels per urinmy bladder were examined by this procedure. In these 
sections, we determined the percentage of the basement membrane that was covered with CIS 
(BMC). Fmihermore, we determined the time-course of CIS formation at early time-points 
(14 days to 2 months) by recording the number of cytokeratin 19 positive single cells, groups 
of2-5 cells, 5-10 cells or more than 10 cells. 
P 53 mutation analysis 
From ill vitro cultured TCC cells DNA was isolated lIsing standard phenol-chloroform 
extraction. Exons 5 - 8 from the p53 gene are each amplified with published primers lS . 
PCR was perfonned \vith J -3 ~tl isolated DNA in a final reaction volume of 15 ~tI containing: 
1.5 mM MgCI" 0.02 mM dATP, 0.2 mM dGTP, dTTP and dCTP each, 0.8 ~ICi «-"PdATP 
(Amersham, Buckinghamshire, UK), 20 pmol of each primer and 0.2 unit Taq polymerase 
(Promega, Madison, \VI, USA). PCR was performed for 35 cycles (denaturing at 95°C for 30 
s, annealing at 55°C for 45 s and extension at 72°C for 1 min) in a Biometra thermocycler. A 
final extension \vas carried out at 72°C for 10 min. PCR products \vere diluted with loading 
bntter (95% fonnamide, 10 nltV! EDTA (pH 8.0), 0.025% bromophenol blue and 0.025% 
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xylene cyanol), denatured at 95°C for 4 min and snap-cooled on ice. For SSCP analysis the 
samples were 11m overnight at 7\V on a non-denaturing 6% polyacrylamide gel containing 
10% glycerol in I x TBE llmning buffer. After electrophoresis, gels were fixed in 10% acetic 
acid, dried on blotting paper on a vacuum gel dlyer and exposed to X-ray tllm overnight at-
70°C, using intensifying scrcens. Films \vere evaluated by visual inspection. 
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Results 
Establishment a/CIS and invasive carcinoma ill denuded mOllse bladder 
Overstretching of the mouse bladder resulted in detachment of urothelial cells with 
focal loss of the total urothelial lining, areas with one epithelial cell layer and areas with no 
detectable loss of urothclium. Collagen type IV staining showed that the basement membrane 
was preserved in the areas where the urothelium had dctached (Figure lA). Earlier 
experiments have shown that within five days after denudation the bladder wall was 
completely reepithelialized 19• Here we noted attachment ofTCC cells to the damaged areas in 
the urinaIY bladders at one hour after the inoculation (Figure 1 B). 
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Figure I: Short-term e/rects (~r overstretching 0/ the mouse bladder and subsequent 
inoculation of TCC cells. A) Partial denudation of mouse bladder urotheliufII one hOllr a.tier 
overstretching without inoculation of TCC cells. Areas with lolal denudatioll 0/ the 
urothelilflJl afe highlighted hy the selective attachment of Indian ink (hlack). Note that the 
basement memhrane as \'isllalized by Collagen type IV (brown) is presen'ed a.tier del/Ill/ation; 
magll(fication IOOx. B) Inoculation (~t TCC cells Oil denuded Madder wall: attachment (~t 
RCK10S-stained 1207 cells (brown) to damaged areas in the urothelium a/ 1 !Jour; 200x. 
Inoculation of TCC cells in partially denuded bladder results in formation of CIS 
and/or invasive tumors in the bladder at 1 to 2 months Cfablc I). Howcver, there was a 
considerable heterogeneity among the various ceillincs in tumor take, growth and localization 
in the urinary tract. Take rate in the bladder varied between 100% (1207) and 63% (R T 112). 
Formation of CIS varied among the diHerent cell lines from 38% to 70%. For RTl12 and 
especially T24 mainly single tumor cells (Figure 2A) or small clusters of hllllor cells ,vere 
present in the urothelium, with a low proliferative activity and high number of tumor cells 
with m0l11hoiogicui signs of apoptosis (data not shown). On the other hand, large areas of 
lining urotheliul11 were replaced by either SD or 1207 cells (Figure 2B-C). Staining with 
collagen type IV antibody confirmed that the CIS areas were really confined to the urotheliulll 
and had 110t penetrated the basement membrane (Figure 2D). 
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Table 1. Take Rate and Growth oflnoculated TCC Cell Lines after Partial Denudation of the Urinary Bladder ofSCID Mice 
Cell line Number of mice Tee implants Bladder Kidney Tee implants in 
in the urinary the ducts of the 
tract Total Invasive CIS PN' 
Tumors clitoral gland 
(%) (%) (%) (%) (%) 
SD 7 717 617 217 417 717 617 617 
(86%) (29%) (57%) (86%) (86%) 
T24 7 717 617 117 5/7* 5/7 417 217 
(86%) (14%) (71%) (57%) (29%) 
RTl12 S 7/8 SIS 218 3/8* 6/S 5/S 5/8 
(63%) (25%) (38%) (63%) (63%) 
1207 10 10110 10/10 3IIO 7110 9110 0110 5110 
(100%) (30%) (70%) (0%) (50%) 
1) PN = pyclo~ncfriti$; * - mainly single cells in the urothclium. 
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Figure 2: Tumor implants ill the urinm:}' tract of the SCID mouse. A) Single RCK108-]1ositive 
T24 cells (brown) ill the IIro/helium of the mouse; magl1{fication 200x. B) Formatioll (~f' CIS 
aller illoclIlaliall IIt'SD alld C) 1207 cells ill dellllded h/adde/'; 400.\". D) Seclioll 1I'ith 1207-
dcrh'ed CIS double stained with RCK I 08 (red) and Collagen type IV (brown) antibody to 
cOJ!{irm tliat Ihe tumor area r" cOII/illed to the lIro/helium,' 200x. E) Detail of a SD-del'h'ed 
llIuscle invasive tumor in the bladder; 200;'(. F') SD tumor ill the ducls (~f' the clitoral gland; 
50.\". 
Although the SD cell line forms CIS in 57% of the mice, in two mice (29%) highly invasive 
bladder tumors (Figure 2E) \vere found. Also in the case of 1207 superficially invasive 
bladder tumors (30% of the cases) \'lere detected, additional to areas with CIS. 
Strikingly, TCC implants \vere found repeatedly in the ducts of the clitoral glnnd, 
which empty into the urethra (Figure 2F). These implants are probably the result of 
mechanical damage to that area by the catheter. Furthermore, a high percentage of tumor 
involvement in the kidney onen accompanied by pyelo-ncfHtis was noted, which could be the 
result of reflux of urine containing tumor cells at the beginning of the experiment. No distant 
metastases \vere found in any of the mice, but in mice inoculated \vith SD or RT112 cells 
local metastases were found in the regional lymph vessels of the bladder and the kidney. The 
occurrence of these local metastases \vas ahvays accompanied by invasive tumors in either the 
bladder or the kidney. 
From this experiment, we concluded that inoculation of 1207 cells in denuded mouse 
bladder is the most promising model for the shldy of CIS, because it had the highest 
frequency of CIS in the bladder, and long tenn experiments were less likely to be hampered 
by 1ll0l1ality due to tumor spread. 
P53 lIIutation (fIUl~vsis 
Spmck et al. reported that 65% of CIS had a p53 mutation Il. Therefore, \ve perfol111ed 
1'53 mutation analysis on the variolls TCC cell lines to test whether CIS-formation was 
correlated \vith the presence or absence ofp53 mutations in these cell lines (Figure 3). All cell 
lines contain one or more p53 mutations in exon 5 - X, which is in concordnnce with the 
observed p53-overexpression in the CIS-lesions. 
I 2 
Figure 3: PCR-SSCP tp53 exol/ 5 00207. 
In exon 5 (~l the tp53 gene an aberrant SSC? 
patlem (arrows) was seen in the 1207 DNA. 
Lane J DNA Fom cell line J 207, lanc 2 1I0rl1/al 
cOlltrol D}/A. 
Growth and extcnt 0/1207 derived CIS ill the bladder 
To further denne our in vivo model of 1207 derived CIS in the bladder we studied its 
extent during six months after the inoculation of the l207 cells (Table 2). CIS of the urinary 
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bladder was observed in 97% of the cases. The contlnement to the urothelium of all these CIS 
lesions was shown by visualization of the basement membrane by collagen type I V antibody. 
Only in two mice, besides a number of areas ''lith CIS, a separate invasive bladder tumor was 
detected at I months and at 6 months after intraluminal inoculation, 
Table 2. Growth of 1207 Derived CIS in the Mouse Bladder 
14 days I month 2 months 5 months 6 months 
Number of mice 5 to to 5 5 
Tee/mouse 515 tOil 0 8110 4/5 4/5 
CIS vs, Invasive 5 CIS 10 In\'. 9 CIS II In\" ~CIS/OInv. 4CIS/OInv. 4 CIS II Inv, 
PN1/t-,·[ice 2/5 7110 411 0 ND5 ND 
U 2 in CIS (mcon ± SEM) 18,4 ± 6,7 13.~ ± 5.2 t9.3± 5.4 18,6 ± 6.2 29.1 ± 6,3 
AI·1 in CIS (mean ±SEi\·l) 1.0±IA 2.5 ± 0.6 3.7± 1.9 ND ND 
mvlC-4 0.9 1.0 3.2 22.6 44.7 
1) PN - pyelo-ncfritis; 2) LI - labeling index; 3) AI - opoptotic index, 4) mv[C - % basement membrane 
covered by CIS-4, 5) ND = not determincd. 
Probably as a result of the procedure, a high percentage of pye!o-nefritis was detected 
in the mice. In contrast to the first experiment no tumors were found in other parts of the 
urinary tract. 
Subsequently, ''Ie determined the dynamics of the onset of CIS. This was achieved by 
following the clusters of t 207 cells within the urothetiul1l during the early stages of CJS-
formation (Figure 4). The number of aggregates of intraepithcliai confined tumor cells 
increased with time. Beyond two months, large areas of the urothelium arc gradually replaced 
by CIS (Table 2; BMC), reaching an average of 44% at 6 months. The grmvth potential of the 
CIS lesions, was filrther substantiated by the high proliferative activity and low apoptotic 
index in CIS throughout the whole experiment (Table 2). 
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Strikingly, the number of Ringle tumor cells within the urotheliu111 was high at 14 days, 
fell at I 1110nth and subsequently rises again at 2 months. Stepwise sectioning and staining 
with RCK108 of bladders obtained at two months uner inoculation revealed that most of these 
single hunor cells and small clusters of tumor cells could be traced back to a nearby located 
area of CIS. This suggests that these single cells can be regarded as the pagetoid spread of a 
nearby CIS. 
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Discussion 
Here \ve describe the development of a new in vivo model of CIS of the urinary 
bladder. \Ve demonstrated that intraluminal injection of established human TCC cell lines in 
denuded mouse bladders consistently resulted in bladder implants. Cell line 1207 generates 
isolated CIS in the urinary bladder in a high frequency, \vhile complications like invasive 
carcinoma and metastatic disease were VClY limited. This makes 1207 the most suitable 
human TCC ceil line to shldy CIS in vivo. 
The growth of the 1207 cell line after inoculation in the urinalY bladder was monitored 
for six months. The extent of the CIS was steadily increasing (Table 2 & Fig. 4). During the 
six months period the areas with CIS were highly viable as reflected by their high 
proliferative activity and their low apoptotic index. Invasion was rarely noted in these 
experiments (Table 2). Strikingly, in a previous experiment, where 1207 cells were injected 
into the submucosa of the bladder, invasive bladder tumors were formed within 2 months, 
with an ulcerated surface (Chapter 5). This lattcr indicates that these same 1207 tUlllor cells 
have the ability to degrade the basement membrane. Inoculation of 1207 cells 011 partially 
stripped urothelium apparently prevents the invasiveness of J207 cells. This could suggest 
that the stromal microenvironment promotes the invasion of 1207 cells, whereas that of the 
urotheliul11 can prevent the invasion of 1207 cells. 
An interesting feature of CIS is the existence of individual or small groups of 
transfollllcd cells in the normal urothelium adjacent to CIS. This pagetoid type of infiltration 
is recognized in a considerable proportion (± 10%) of CIS of the human bladder2o. By 
mapping studies we found out that a substantial part of the detected single tumor cells at 2 
months could be regarded as the pagetoid spread of a nearby located CIS. The ability for 
pagetoid intraepithelial spreading of 1207 cells is in accordance \vith the results of our in vitro 
cocu1tivation model, in ,vhieh 1207 cells infiltrate the surrounding normal urothelium as 
single cells21 • 
It is generally accepted that CIS can be regarded as the precursor lesion for invasive 
bladder carcinoma6. 12. However, the results from our in vivo model showed that inoculation 
of otherwise highly invasive TCC cell lines could give rise to the formation of CIS. This 
suggests that CIS should not only be regarded as a staliing point for the progression to 
invasive carcinoma, but it can also be the result of an alternative mechanism of tumor spread 
130 
of high grade invasive carcinoma. 
Furthermore, a proportion of the detected CIS consisted of isolated large intraepithelial 
lesions in the bladder, whieh were covered by large umbrella cells. According to the \VHO 
grading system these lesions which do not replace the full thickness of the urothelium are 
called dysplasia, instead of carcinoma in situ22 . However, the fact that in our model 1207 
tumor cells, originally obtained from a highly invasive tumor, gave rise to such lesions 
suggests that dysplastic lesions can harbor malignant hllllor cells and as such they carry a 
substantial risk of development into an overt carcinoma. This implies that pathologist should 
be aware of this risk whenever they come across a dysplastic lesion in the bladder. 
Previously, other animal models for the generation of CIS of the bladder \vere 
described. Treatment of laboratOly animals with carcinogenic agents like dibutylnitrosamine 
(DEN), N-butyJ-N-(4-hydroxybutyJ)nitrosallline (EEN), N-methyJ-N' -nitrosourea (MNU) N-
(4-(S-nitro-2-fmyJ)-thiazoJyJ forlllalllide (FANFT) and Bracken Fern can induce CIS of the 
bladder2J .26 • Major drawbacks of these procedures, like the high incidence of papillmy and 
invasive tumors, a long lag time, toxicity to the animal, possible carcinogenicity to other 
organs, and the often-observed predominance of squamous differentiation, make theIll less 
attractive as a model of CIS. Earlier reports on the xenogratling of established bladder 
carcinoma cell lines in bladders of immunodeficient hosts showed Imv formation of CIS27-3o• 
In these models a high incidence of papillary or invasive bladder tumors is repOlied. 
Furthermore, because the inoculation of bladder hunor cells in intact bladders is largely 
prevented by an intact bladder surface, most of these studies used chemical agents or local 
trauma to promote tumor take!5,31. However, a major limitation of the latter traumatizing 
procedures is the chance of deep penetration of the bladder wall thereby fhcilitating tumor 
invasion27. Obviously, in our model, overstretching of the bladder wall did not result in 
ruphlre of the basement membrane and its underlying tissues. This was shO\vn by the 
preservation of collagen type IV in areas with total loss of the urotheliulll (Figure IB). 
Apparently, this resulted into a high frequency of CIS. In earlier experiments we have shown 
that intra-mllscular inoculation of human TCC, including 1207 led to invasive growth 
(Chapter 5). Therefore it can be argued that preservation of the basement membrane by 
employment of a mild procedure to denude the urothelial mucosa may have led to the 
observed low occurrence of invasive hUllors after inoculation of 1207 cells. 
In conclusion, the 1207-derived CIS of the bladder is a new, promising and 
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reproducible model for the study of the behavior of CIS. Since the 1207-derived bladder 
tUlllors seem to persist as intraepithelial tumors for a long period (up to six months) it makes 
them a highly suitable model for the development and testing of intravesical chemo-, 
immul1o- or gene-therapy. 
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Chapter 7 
GENERAL DISCUSSION 

The major problem in the management of superficial bladder carcinoma is the high 
frequency of recurrences after local resection of the primary tumor. Hypothetically, reseeding 
and/or (subsequent) intraepithelial expansion (lEE), are two obvious mechanisms that could 
explain the high recurrence rate of bladder tumors. To study both mechanisms relevant model 
systems are needed. In tillS thesis we described the development of useful i11 vitro and in vivo 
model systems of lEE. Subsequently, the described model systems were used ill an attempt to 
identify factors that influence lEE. 
In vitro intl'aepithelia/ expansion model 
In our in vitro model, lEE can be considered as the outcome of the balance betwecn the 
expansion and proliferation of the neoplastic ceUs and the potential of the surrounding normal 
urotheliuIll to regenerate. TIils implies that besides the intrinsic characteristics of the tUIllor cells, 
the host environment also influences lEE (Figure 1). In chapter 2, we have shown that we can 
shift the balance towards the normal urothclium by specific stimulation of its regenerative 
capacity by growth factors. 
Figure 1: COIIIl'ol of lEE/lEN. Eslablished und suggesled medialars (a 1/111 g; see lext) iJ( 
lEE/lEN are depicted (U= urothelium; Bl'vi= Basement membrane; black= lEA? 
E-cadheritHuediated cohesiveness is an imp0l1ant intrinsic characteristic (Fig. 1. a), 
which determines the IEE-capacity of TCC cells (Chapter 4). However, E-cad~lerin is not the 
sole mediator of lEE, since the E-cadherin positive cell line JON hardly showed any lEE. TItis 
means that also other, yet unknown factors participate in lEE. For instal.lce integrins-ECM 
interactions will be involved in the reseeding of tumor cells on the basement membrane (Fig. 1 c) 
and will probably also be involved in the latcral spread (Fig. 1 e) along the bascment membrane. 
The importance of the latter is con'oboratcd by Harabayashi et al., who noted in their in vitro 
model that a reduction of integrin p4-expression in tumor cells as well as an enhanced nilgration 
on lal11inin are involved in lEE (Harabayaslil et ai" 1999). Recently, we investigated the 
involvement of ECM-proteins in the lateral spread of ihtraepitheliai bladder hunors. \Ve 
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compared the lEE capacity of the TCC cel1lines with their expansion on collagen type IV-coated 
membranes in the absence sUlTOlll1ding urotheIiu111 (Table 1; unpublished resulls.). 
Table 1: Comparison of lEE (with surrounding lira/helium) and e.\1)(I11Siol1 011 Collagen type 
IV in the absence o[surrounding umlheliulJI. 
lEE Expansion on Call. type IV 
SD ++ ++ 
T24 ++ 
RTI12 + +/-
J82 +/-
1207 + +/-
Jon +/-
Strikingly, we observed that the expansion on collagen type IV not always correlated with the 
lEE, For instance, the observed lEE ofRTl12 was proportionally stronger than its expansion on 
collagen type IV coated membranes in the absence of surrounding urothelium. This suggests that 
the eocultivation ofRTt 12 with non11al urothelial cells facilitate its lEE. We indirectly examined 
whether excretion of a paracrine substance or deposition of a specific component on the culhlre 
substratum stimulates lEE of RTll2 cells, \Ve noted that culhlring on mouse urotheliulll 
deposited eulhlfe substratum but not mouse urothelium conditioned mediulll (Figure 2) 
stimulated the expansion ofRT 112 cells in the absence of surrounding urotheliulll. 
Mouse urathelium deposited substratum consists, besides the already coated human collagen 
type IV, of at least fibronectin, mouse collagen type IV, and laminin (unpublished results). By 
further studies we could demonstrate that fibronectill depositions are probably the most 
impOltant HlCtor, which contributed to the enhanced expansion of RT1l2 (uNpublished results). 
These results gave fillther proof of the involvement of intcgrins-ECM interactions in lEE (Fig, I 
e). 
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Figure 2: b!/luellce (?i'mouse lira/helium conditioned medium (0\1) 01' basement memhrane 
deposited by mouse bladder cultures (Bl\{ l"fBC) all the e.\pan.<:ion of RTl12 cultures in the 
absence afsurrounding norma/ura/helium. (CollIV= collagen IV; SA1= standard medium). 
Cross-sections of the cocultivations revealed that, like the in vi\'o situation, our Tee cell~ 
expand in lEE by undermining (Fig. 1 f) the normal urothelium (Chapter 2). UJtra-struchlral 
analysis showed that ill vitro the normal mouse urotheIiul11 is anchored to the basement 
membrane by hcmideslllosol11CS. Obviously, tumor cells have to dismpt these hemideslllosomes 
before they undenninc the adjacent urotheliul11 (Fig. 1 f), The question remains, how can this be 
accomplished by the tumor cells'! Is mechanical disl1lption sufficient or is targeted disl1lption by 
specialized "invadopodia~like stl1letures" necessary'! These invadopodia are cell membrane 
protl1lsions which exhibit a coordinated expression of integrins/receptors for proteolytic enzymes 
and specific protcolytic enzymes, and they arc 110nnally involved in disruption of ECM proteins 
(Kelly elal., 1994; Salo el al., 1994; Brooks el al., 1996). 
The production of paracrine substances (peptide grO\vth factors, cytokincs, etc.) by the 
nonnal urothelium could influence the behavior of intraepithelial tumor cells and vice versa (Fig. 
1 d), The imporlance of the host environment (Fig, 1 b,d) on lEE was suggestcd by several 
authors (Orozco et al., 1994; Rebel et al., 1995; Chapter 2), Modulation of the sUlTounding 
normalurothcliull1 by growth factors or ECM~proteil1s resulted in an altered lEE of tumor cells 
(Rebel el al., 1995; Chapter 2). Orozco el al. suggested that, based on the discrepancy in 
biological behavior of CIS, some patients possess yet unidentified resistance factors for the 
progression to invasive disease (Orozco el al., 1994), These patients have CIS~lesions, \vhich 
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exclusively grow in an intracpithelial environment and which usually do not even invade when 
the adjacent urothelium is heavily damaged (Orozco et al., Murphy et al., 1994). 
Recently, lavaherian et al. showed that surrounding normal keratinocytes could suppress 
the intraepithelial growth of malignant keratinocytes (lavaherian et al., 1998). They proposed a 
mechanism wherein cell contact with nonnal epithelial cells induces cell cycle arrest and 
tcnninal differentiation of tumor cells. Similarly, one could wonder, what will be the fate of 
single T24 cells (Fig. I g) that infiltrated the normal sUiTounding urothelium'l Could direct 
contact between tumor eells and normal cells prevent the further clonal outgrowth of hllnor 
cells? \Ve shldicd the expression of cell cycle and apoptotic markers in single T24 cells. 
Dispersed T24 cells still have a high proliferative activity (MIB-l, BrdU), and hardly show 
expression of p27 (marker for quiescent cells) (ulljJuh/t:s'/zed results). These preliminmy data 
suggest that the normal urotheliul11 had 110 direct effect on the growth of dispersed T24 cells. 
However, in our ;,/ vivo model of lEN, single T24 cells often had morphological signs of 
apoptosis and were discarded from the urothelium by shedding. The latter suggests that shedding 
of single tUl110r cells could indeed affect the ability ofT24 for lEE (Fig. I g). 
In vivo model (~OI1(raepitheliallleoplasia 
Inoculation of 1207 cells in partially denuded bladders resulted reproducibly in the 
fi'cquent t0n11atiol1 ofIEN. Only in isolated cases, invasive carcinomas of 1207 ceUs were found, 
which were probably due to the disruption of the basement membrane during the overstretching 
of the bladders in our initial experiments (Chapter 6; experimcnt 1). Long term follow-up 
showed that in our model no progression from 1207 derived-lEN to invasive carcinomas 
occun'ed (Chapter 6). Tn contrast, inoculation of 1207 in the submucosa of the bladder gave rise 
to invasive bladder hunors (Chapter 5). There are a few possibilitics to explain this difference in 
behavior of 1207 cells in the two in vivo assays. First, in the case of our ill vivo model of lEN, 
cells could be selected that gave only rise to lEN. Sccond, possibly a longer period of time has to 
pass before the progression to invasive disease evenhmlly will occur. This is however highly 
doubtful, because even after a follow-up period of I year (unpublished results) there arc still no 
signs of progression. Third, the specific microenvironment could either stimulate (submucosa) or 
block (urothelium) the invasive behavior of 1207 bladder tumor cells. The latter would give 
fmiher evidence for the importance of the host environment in lEE (Fig. I b), provided that the 
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intraepithelial environment indeed promotes lEN~behavior of the 1207 cells. 
Future research 
Many of the conclusions drawn in this thesis (Chapter 2 & 4) are based on our xenogenic 
cocultivation model. \Ve are well aware that we can not exclude that some of our findings could 
be due to differences bctwcen the two species. To address this problem, future research should 
focus on the development of an allogenic coeultivation model. Problems concerning the 
availability of human biomaterial and the specific labeling of tumor cells have to be solved 
before this approach can be successful. 
To study the role ofintegrins~ECM interactions in lEE, initial shldies should focus on the 
flowcytomctric analysis of intcgrin~expression and study the expansion of the various Tec cell 
lines on mouse urothelium deposited culhlre substrahlln. Investigations, which compare the 
exposure of the cocultivations to various ECM-components, ,viII probably not resolve the issue, 
bccause exposure to ECM-protcins would affcet both tumor cell behavior and composition of the 
Bannai urotheliulll. Con'elation studies behveen the integrin expression and lEE behavior of 
tumor cells hopcfblly will give suggestions of specific integrins that are involved in lEE. Next, 
transfection of TCC cell lines ''lith these specifle integrins or the creation of knockouts, and the 
subsequent testing of these modified cells in our cocuItivation assay could fmiher substantiate 
the role ofintegrins-ECM interactions in TEE. 
We have conducted initial shldies on the £1tC of single cells (T24, etc.). Still marc 
accurate evaluations of the expression of apoptotic and proliferation markers in these dispersed 
cells arc nceded. Fmihermore, fluorescent labeling of TCC cells and the subsequent ex vivo 
shldy, using confocal microscopy, could reveal whether shedding is involved in the elimination 
orlhese cells. 
Confocal microscopy can also be helpful in the study of the presumed targeted 
expression of combinations of integrins and proteolytic enzymcs in "invadopodia-Iike stl1lctures" 
at the fl'ont of undermining bladder tumor cells (Fig. 1 f). 
The described ill vivo model can be used to design therapics that prevent/block the 
growth of intraepithelial neoplasia and its progression to invasive bladder carcinomas, 
Fmihennore, the results of our ill vitro lEE assay can now bc extrapolated to the in vivo lEN 
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model. For instance) T24 cells stably transfcctcd with E-cadherin or TCC cells with modified 
integrin expression can be studied in our in vivo model and this could demonstrate whether these 
molecules stimulate the fonnatioll of lEN in vh'o. 
Finally) if selection of 1207 cells ,vmIld take place in our in vivo model ofIEN) it would 
also be wOlthwhile to characterize these cells and compare them with the native 1207 cell 
population. This could give us fmther insight into the intrinsic features of tumor cells that 
contribute to lEN. 
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Chapter 8 
SUMMARY/SAMENVATTING 

SlIIllnHlry 
Bladder cancer is the fifth most common malignancy in males in the western society. 
At initial presentation, ± 65% of the patients has superficial transitional cell carcinomas. The 
remaining patients have invasive bladder tumors. A big problem in the management of 
superficial bladder cancer is the high frequency of tumor recurrences after local resection. 
Based on the presumed monoelonality of these recurrences, the nYo most obvious 
mechanisms to explain these reculTences are: I) Intraluminal shedding with subsequent 
attachment of tUlllor cells to traumatized or intact areas in the urothelium; 2) Lateral 
(intraepithelial) migration of tumor cells into the normal surrounding urothelium. This thesis 
describes the development of two model systems, which were used to study the role of the 
above mechanisms in bladder hunor recurrences. 
In chapter 2, ,ve describe a new cocultivation model for the study of lateral intraepithelial 
expansion (TEE). In this model, human bladder hllnor cells were seeded on top of traumatized 
confluent organotypie mouse cultures. These tumor cells preferentially attached to the 
traumatized areas in the culhlres. After implantation, hUllor expansion at the expense of the 
normal surrounding urotheliul11 could be accurately monitored. The implantation and 
subsequent lEE of bladder carcinoma eell lines, SD and T24, were studied. SD cells expanded 
into the normal urothelium as a f.:1st growing, sharply demarcated tumor. In comparison, T24 
cells infiltrated the normal urothelium as single cells and displayed a slow, but gradual 
expansion. Next, ,ve shldied \vhether stimulation of the regenerative capacity of the normal 
urotheliulll could alter the implantation and lEE of SD or T24 cells. Addition of EGF 
(epidermal growth factor) stimulated the proliferation of the normal urothclium, and reduced 
the implantation and growth ofT24 cells considerably. The implantation of SO cells was also 
reduced by addition ofEGF, but EGF could not prevent the subsequent expansion of the SD 
cells. Furthermore, we shmvcd that EGF had 110 effect on the proliferation or migration ofT24 
or SD cells. These results suggested that modulation of the host environment (stimulation of 
regenerative capacity of thc normal urothelium by EGF) could reduce implantation to 
,vOllllded urothelium, and in some instances could alter the lEE of tumor cells. 
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The effect of EGF on lEE stimulated us to study the role of the EGF-EGFR family during 
urothelial regeneration in more detail (chapter 3). EGF, TGFa, and to a lesser extent 
amphiregulin stimulated wound regeneration of nonnal human urothelium ill vU1'O. Since these 
growth factor treatments had no general effect 011 urothelial proliferation during wound healing, 
the enhanced regeneration could be primarily attributed to an increase in cellular migration. 
C-erbB2 plays an impOliant coordinator}' role in the function of the EGFR h1mily. Therefore, the 
role of c-erbB2 in urothelial regeneration WflS fmiher investigated with the use of antisense DNA 
specific for c-erbB2. Urothelial rccpithelialization could be delayed up to 50% by antisense c-
erbB2, but not by mismatched or sense c-erbB2-0Iigonuclcotides. The proliferative capacity of 
the urothelial cultures was not altered after treatment with any of the oligonucleotides. This 
suggests that c-erbB2 is a regulator of migration dming urothelial wound healing. 
Using our ill vitro cocultivation flssay, we compflrcd the lEE of a panel of six bladder 
carcinoma cell lines (chapter 4). Tn this way, we hoped to identify factors intrinsic to tumor 
cells that determine rEE. lEE was most pronounced in three (SD, RTI 12, and 1207) of foUl' E-
cadherin positive celllilles. In contrast, the two E-cadherin negative cell lines (T24 and J82) 
were hardly able to expand into the normal urothelium. This suggests that E~cadherin is an 
important mediator of rEE. To further test this assumptioll) we transfected T24 cells with full-
lcngth mouse E-cadherin cDNA. Only T24 clones \vith a high) functional expression of E-
cadherin displayed an enhanced lEE expansion rate. Transfection did not alter their 
proliferative capacity, or their pattern and level of integrin expression) or their ability to 
expand on collagen type IV coated membranes in the absences of urothelium. These data 
suggest that E-cadherin-mediated cohesiveness is un important determinant of TEE of bladder 
carcinoma cells. 
In general, intraepithelial neoplasia (IEN) is considered as an important precursor lesion of 
invasive bladder carcinoma. However, not all observed lEN will ultimately lead to invasive 
disease. Therefore) in chapter 5, we investigated the invasive capacity of the previously used 
bladder carcinoma cell lines. This has further characterized our panel of cell lines) find 
hopefully will contribute to the future understanding of thc paradoxicfll behavior of lEN) like 
CIS. In other organ systems it was demonstrated that the microenvironment has an imp0l1ant 
influence 011 the bclmvior of tumor cells. To investigate the importance of the 
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microenvironment in bladder cancer invasion, bladder carcinoma cell lines were tested in both 
il1 vitro and in vh'o invasion assays. III vitro invasion into emblyonic chicken heart fragments 
was inversely correlated with their E-cadherin expression. However, the results of this ill vitro 
assay could not predict ill vivo invasiveness. The ill vitro non-invasive cell line SD formed 
highly invasive tumors in vivo. This could be ascribed to the observed heterogeneous 
expression of E-cadherin in these SD tumors. In addition, we also observed site-specific 
hllllor take for 1207 and T24 bladder carcinoma cells. These results show that the urinary 
bladder microenvironment indeed plays an important role in tumor growth (1207 and T24) 
and in the induction of the invasive phenotype (SD). 
Taken together, the results described in chapter 4 and 5 suggest that E-cadherin plays a 
paradoxical role in bladder tumorigenesis. On the one hand, E-cadherin promotes the 
expansion of intraepitheli<ll neopi<lsia; on the other hand, its loss correlates with inv<lsive 
behavior of bladder tumors. 
To extrapolate our in vitro findings to the more complex situation of humans, relevant in vivo 
models are needed. To establish an in vivo model of lEN, bladder carcinoma cells were 
intraluminally injected in partially denuded mouse bladders (chapter 6). The denuded bladders 
were rapidly recpithelialized with mouse urothelial cells and the injected tumor cells. Four 
TeC cell lines were compared for their ability to form LEN. All four cell lines showed 
tormation of lEN. However, there were considerable differences in the frequency of lEN 
formation. Furthermore, invasiveness and development of tumors elsewhere in the urinary 
tract were also observed. Cell line 1207 was identified as the most promising and useful 
model of lEN, because this cell line revealed the highest frequency of lEN in the bladder, and 
long-term experiments were less likely to be hampered by invasive carcinoma or metastatic 
spread. In the following time-course experiment, we studied the growth chamcteristics of 
these 1207-derived lEN during six months. In this experiment, 1207 again displayed a 
frequent formation of lEN, and invasion was only found in isolated cases. During the six 
months period, 1207-derived lEN showed signs of gradual intraepithelial expansion. The 
growth of these 1207-dcrived lEN was based on a high proliferation rate <lnd a low apoptotic 
rate. Intraluminal injection of 1207 cells in partinlly denuded bladder results in a highly 
reproducible model for the study of the behavior of lEN. In addition, our model also suggests 
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that formation of lEN can bc the result of an alternative mechanism of tumor spread of high~ 
grade invasive bladder carcinoma. 
Smllenvatting 
Blaaskanker is in de westerse samenleving dc vijfdc meest voorkomende maligniteit. Van de 
patiCntcn met overgangscpithccJ carcinoom van de urineblaas hceft 65% supcrficiclc 
tumorell. De overige patienten hebbcll invasief blaascarcinoom. Een groot probleem in de 
behandcling vall de supertlcieJe tumoren is het hoge reddicf pen:entage en de kans op 
progressie na locale resectie van de primaire tUInOr. Uitgaande van de verondersteldc 
1ll0noc1onaliteit van blaastul11oren, zijn er hvee mechanismcn mogelijk, nl.: I) loslatcn van 
blaastumorcellen van de primairc hnBor, gevolgd door hechting van blaastumorcellen op de 
(verwondde) blaaswHnd; 2) Laterale (intra~cpithclialc) migratie van hlll10rccllcn in het 
norma Ie urotheel. Dit procfsehrifl beschrijft de onhvikkeling van twce model systemcll, die 
gebruikt \verden 0111 de ral van beidc mcchanismen bij de vorming van blaaskanker 
recidieven tc bcshlderen. 
In hoofdstuk 2 wordt een nieuw coeultivatic model beschreven. In dit model, worden 
suspensics van humane blaastumorcellen uitgezaaid op een bcschadigde culture van urothccl 
van de muizenblaas. Na hechting van de tumorcellen in de beschadigdc gebieden, kan de 
expansie van deze tUl110rcellen ten opzichte van het omringende, nOllllale urathcel worden 
onderzoeht. 
Dc hechting en de daaropvolgende intra~cpitheliale expansie van de hvee humane blaaskanker 
cellijnen SD en T24 werden in dit model onderzoeht. Dc SD tumorcellen expandccrden als 
cell snel graeiend, schcrp bcgrensd veld zander infiltratie van het nOl'male urothcel. 
Daarentegen expandeerden T24 tUl110rcellen langzaal11, waarbij individuele T24 tumorcellen 
het Ilormalc urothecl intlltreerden. Vervolgens werd bcshldccrd of stimulatie van de 
rcgencratieve capaciteit van het normanl uratheel, de hechting en intra~cpitheliale expansic 
van T24 of SD cellen kon bei·nvloeden. Epidermale grod factor (EGF) stimulccrde de 
pro1iicratic van het 11onna1e urotheel en zorgde voor een gereduceerde hcehting en groei van 
T24 cellen. De hechting van SD cellen wcrd evencens geredllceerd door toevoeging van EGF. 
Er vond cehter geen remming plaats van de expansieve groei van de SD tlll110rcellen na EGF~ 
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toevoeging. Het veranderd gedrag van beide tumorcellijncn kon niet toegeschreven worden 
aan een door EGF~gei'nduceerde verandering van de proliferatieve of migratoirc activiteit van 
be ide tumorcellijnen. Dit sliggerccrt dat stimulatie van de rcgcncratieve capaciteit van het 
nornwal urothcel kan lei den tot een vermindenle hechting van blaastumorcellen op 
beschadigd urotheel en cveneens in sommige gevallell in een veranderde intra~epitheliale 
expallsie van blaastumorcellen. 
Het effect van EGF op de intra~epitheliale expansie stimuleerde ons om de 1'01 van de 
EGF/EGF~receptor familie tijdcns de regeneratie van bcschadigd urotheel nader te 
olldcrzoeken (hoofdstuk 3). De ill vitro I'cgeneratie van nonllaal humaan matheel \verd 
gestillluleerd door toediening van EOP, TGFa of amphireguline. Dit effect kon voornamelijk 
tocgcschreven worden aan een tocgenolllen migratie van urothce1cellen, die zorgden voor het 
sluiten van de bcschadiging. C-erbB2 fungeert als een bclangrijke coordinator voor de functie 
van de EGF-receptor fhmilie. Daarom werel de rol van c-erbB2 tijdcns de regeneratie verder 
onderzocht door het gebl1lik van een antisense-DNA strategie. Regeneratie van het uratheel 
werd anllzielllijk gcrellld (± 50%) door loediening vnn antisense c-el'bB2, tenvijl negatieve 
controles geen effect licten zicn. Dc proliremtieve capnciteit van de beschadigdc 
urotheelkwekcn werd door geen van deze oligonucleotides veranderd. Dit suggereert dal, 
tijdells de regeneratie, c-crhB2 vooral een belangrijke regulator van urotheelcel-migmtic is. 
In hoofdstuk 4 werd de intra-epilheliale expansic van zes verschillende blaaskankercellijnell 
onderling vergeleken in van het eerder besehreven cocultivntic model. Op deze wijze hoop ten 
we intrinsieke factoren vnn de tumorcellcn te identiflceren, die betrokkcn zijn bij hel proces 
van intra-epithcliale expansie. Bij drie van de vier E-cadhcrine positieve cellijnen (SD, RTl12 
en 1207) werd de grootstc intra-cpitheliale expansie waargenolllen. Dit, terwijl de hvee E-
cadhcrinc negatieve celiijnen, T24 en J82, vrijwel geen illtm-epithelialc cxpansic toonden. Dit 
zou k.'1l1lnen betckcn dat de aanwezigheid van E-cadherine cen belangrijke bijdrage levert aan 
de intra~epithelinle expansic van blaastumoren. Om deze aanname venier te onderzoeken, 
werden T24 cellen met het eDNA van E-cadherine getransfecteerd. T24 kionen met 
verschillende mnte van E-cadherine expressie werden in onze cocultivatie assay getest. AIleen 
T24 klonen met een hoge functionele cxpressie van E-cadherine haddcn cell toegenomen 
intra-epithelia Ie cxpansic. Transfeclie van T24 cellen met E-cadherine had geen effect op de 
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proliferatieve activiteit, noch op het expressicpatroon cq. expressicnivcau van verschillende 
integrines, noeh op de expansiesnelhcid op collageen type IV -gecoate membranen in de 
afwezigheid van omringend urotheel. Hiemit kan gecollcludeerd worden, dat E-cadherine~ 
gemcdiecrde tumor-cohesie een bclangrijke bijdrage levert aan de intra-epitheliale expansie 
van blaastumoren. 
In het algemeen ,vordt intra-epitheliate neoplasie in de blaas beschouwd als een belangrijke 
voorIoper van invasief blaasearcinoom. Eehter niet clkc waargenomen illtnl-epithelialc 
neoplasie zal zich olltwikkclel1 tot een invasief blaascarcinoom. Inmiddels is bekelld dat de 
omgeving een belangrijke invloed heeft 01' het invasieve gedrag van tUlllorcellen. Dc 
invasieve capaeitcit van de door ons eerder gcbruikte cellijnen wcrd onderzocht (hoofdstuk 5) 
zowel in in vitro als in vivo invasie assays om meer inzieht te krijgen in de faeteren, die een 
rol spelen bij de progressie naar invasicf gedrag van intra-epitheliale neoplasie. III vitro 
invasie was sterk gecorrclecrd Han de in vitro expressie van E-cadherine. De resultaten 
verkrcgen lllet deze ill vitro invasie assay kondell eehter het invasieve gedrag in vh'o niet 
altijd voorspellen. Bijvoorbeeld, cellijn SD liet in de ill vitro assay geen invasiviteit zien, 
terwijI in vivo hoogst invasievc hunoren werden gevormd. Dit kan mogelijk vcrklaard wordcn 
door een afhame in E-cadherine exprcssie in deze tumoren. Verder werden er bij andere 
cellijnen blaas-specifieke tumorgroei en invasiviteit waargenomen (l207 en T24). 
Bovengenoemde resuitaten latcn zien dat de omgcving waarin een hUllorcei zich bevindt 
inderdaad cen belangrijke rol speelt in de groei (1207 en T24) en invasivitcit (SD) van 
tumercellen. 
De resultaten uit hoofdstuk 4 en 5 suggcreren een paradoxale roI voor E-cadherine in 
blaaskanker. Enerzijds stimuleclt de aamvezighcid van E-cadherinc the intra-epitheliale 
expansic van blaastul11orcellen, anderzijds is verlies van E-eadherine expressie geeon-eleerd 
aan invasief gedrag. 
De eerder ontwikkcldc cocultivatie assay (hoofdstuk 2) is een zeer stcrke vereenvoudiging 
van de cOl11plexe sihmtie, in het geval van blaaskallker bij de mens, Om een betel' inzicht te 
krijgcn in het proees van intra-epithelia Ie expansie zijn daarom relevante dienllodcllen zeer 
gewenst. Om die reden werd door ons een dienllodc1 voor intra-epithclialc neoplasie 
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ontwikkcld (hoofdstuk 6). In dit model worden humane tumoreellen in het lumen van de 
urineblans van een 111uis gei'njecteerd, waarbij eerder een gedeelte van hun urothccl was 
verwijderd. In deze situatie kan een niemve bekleding van de blaas ontstann, die decls bestant 
uit normnal urotheel, decls uit tumoreellen. Vier blaashul10rceliijnen werden op deze wijze 
vergeleken met betrekking tot de vorming van intra-epithelia Ie neoplasie. Dc injectie met 
celiijn 1207 resulteerde het meest frequent in de vonning van intra-cpitheliaie neoplasie, 
terwijl invasieve tumoren zelden gevonden werden. Daarom wcrd besloten 0111 met deze 
cellijll verdeI' te gaan voor de ontwikkeling van cen diermodel. In de daaropvolgende 
experi111entcn werd de groei van intra-epithelia Ie neoplasie in het 1207-tnodel gedurende zes 
mnanden vervoJgt. Gedurende deze onderzoeksperiode werd een gestage groei waargenomen 
van de 1207 tUl110ren zonder invasieve groci. Dc toename V<Ill deze intra-epitheliaie neopinsie 
was het gevolg van een hoge 111nte van proiiferatic en een lage mate van apoptose. Injectie vnn 
1207 cellen in het lumen van gedceltclijk beschadigde Illuizenblazen is een goed 
reproducccrbaar diermodel, dat bruikbanr is bij de stu(lie nanl' het gedrag van intra-epithelialc 
tUl11oren. Onze resultaten sllggereren bovcndien, dat hooggradig, invnsief blaascarcinoom zich 
elders in de blaas kan manifcsteren als intra-epithelinle l1eoplasie. 
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ongebreidelde stroom aan idecen, enthollsiasll1e en het [eit dat je me zeer vrij hebt gelaten om 
dingen te proberen. 
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